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STüDIiSS ON gHE SPIPFÆIOLORY Ml)
miM0k i ii j^nm— g^wwfc»
niwmnoi^ oÿ eubblm
The work for tMs thesis was conduoted between Deoember I965 and 
Deoember I968 at the %ideaiiological Research Xiahoratory^ Central 
Public Health Laboratory ^ Colindale Avenue, LondonN.W. 9«
The aims of the studies undertaken were as follows s
Ic To assess the proportion of women of ohiM-bearing age 
resident in different regions of the United Kingdom who possess 
antibody to rubella with special reference to their age-group, country 
of origin, previous history of rubella and obstetric experience.
2. To observe the differences in rubella antibody titre of the 
various batches of immunoglobulin which are in current use in the 
United Kingdom and to determine, by means of a controlled trial, the 
protective effect of immunoglobulin of high rubella antibody titre 
when given to contacts of rubella who are within the first sixteen 
weeks of pregnancy.
3. To investigate the infeotiousness of the rubella virus in the 
home, in a semi-residential oomiunity and on casual contact with 
patients suffering from the disease * In addition the proportion of 
subollnical and second attacks of rubella that can bo verified by 
laboratory means wore noted.
Although several investigations are described in the thesis, each
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is intended to provide some information on the risk of infection to persons 
especially if in early pregnancy, when they are exposed to the rubella 
virus and to determine the protection they may expect if given immuno­
globulin after contact with the disease. Because it is now possible 
to isolate tlie rubella virus and perform antibody titrations, the results 
of each study was based on laboratory findings.
The investigations were carried out with the help of general 
practitioners, doctors in charge of ante-natal clinics and virologists 
at the laboratories of the Public Health Laboratory Service.
0-
RKSULTS
Immunity to Rubella
■jMWiiin' i*rn
1. The majority of persons investigated already possessed antibody 
to rubella by the time they reached adult life. The proportion 
immune varied in the different geograpMcal areas studied and 
ranged from 96 per oesit of tho women from Leeds and Keighley to
80 per cent of those from London* Taking all the regions into 
consideration 91 per cent of the women examined were inmime.
2, Immunity to rubella varied to some extent with age* Of those 
less than 20 years, 84 per cent were immune compared with over 90 
per cent in older women.
3* Among the immigrant population living in the United Kingdom,
tho African and West Indian populations appeared to have a smaller 
proportion of persons who possessed rubella antibody, 
ij.» The reported history of an attack of rubella did not agree with
the patient’s immnity to rubella*
5. Women without children were more likely to be susceptible to
rubella than women with families*
6* A large proportion (97per cent) of the young adult males
investigated also possessed antibody to rubella*
Immunoglobulin
7* Ampoules from fifteen batches of British immunoglobulin were
tested for neutralising antibody to rubella* All contained
—antibody, the titres ranging from 1 t 60 to 1 î 320*
AttBQjcrate_AB ruteim.AO#aot8_jtlvm Immunog^^
8. (a) When no account was taken of the immunity of pregnant women
in contact with oases diagnosed clinically as MVing rubella, 
only 1.4 per Cent developed an illness with a rash after having 
had an Inoculation of 750 mg* immunoglobulin*
(b) When virologioal studies were performed, however, and the 
analysis restricted to susceptible pregnant women who were in 
home contact with a case of rubella proved by Isolation of the 
virus, then 80 per cent became infected either clinically or 
subclibiically despite having had 750 mg. immunoglobulin *
9» ilven when the dose of imiiiunoglbbulin was increased to 3,000 mg., 
four of six susceptible women developed the disease after contact 
with a confirmed case of rubella.
10* The risk of contracting rubella was much less if the index 
case was not a member of the same household* The attack rat© 
for InoQulatedg susceptible prenant vfome# in contact outside the 
home with i\ oonfimed case of rubella was a quarter of the rate 
found for home contacts.
Attack rate in uninooulated contacts of rubella 
11, Fifty per cent of uninoculated susceptible woman of childbearing 
age developed rubella after home contact with a virologloally 
proved case. As 80 per cant of pregnant women became infected, 
pregnancy may increase ^susceptibility*
“5“
12o In the Hendon Police College - a residential oomffiunity - 100
per cent of those cadets who v/ere susceptible developed rubella 
after the introduction of infection into the college.
Second attacks of rubella 
13. Second attacks of rubella were found to be rare* Only one of
106 immune pregnant mothers developed a second attack of rubella 
following exposure* The clinical diagnosis was verified by virus 
isolation but neither in this woman nor the 105 others did a four­
fold rise in antibody titre occur*
14* (a) The number of subolinioal attacks of rubella in the communities 
studied was probably considerable as judged by the proportion (88 
per cent) of women who possessed antibody to rubella but who did 
not give a past history of clin:lcal infection*
(b) Eleven per cent of uninoculated women and 14 per cent of 
uninoculated men who developed rubella had a subolinioal infection* 
(0) forty-eight per cent of the women who developed rubella after 
immunoglobulin had a subolinioal infection. Immunoglobulin, 
therefore, may suppress the clinical features of the disease b%t not
prevent infection*
Isolation of ;fche rubella virus 
15, Rubella virus was isolated in about 50 per cent of specimens 
obtained from cases of rubella during the first three days after
the onset of the rash* During the next three days the virus was 
isolated from about 25 uer eent of oases s thereafter it was seldom isolât
b r  1 U  L  iVi I u  L  U  Li i b  1, i \  I', b I. A  K  L  I , L  A  U U  K  .A I U  K  \
f Palilic / A V Liihoralory Service)
C l’.N TR AL HF.ALTH LABORATO RY,
TelcphoriC: 01-205 7041 C O L IN O A L E  A X 'LN LL ,
TJecm m s: Lond(jn, NAV.9. LONDON, NAVA.
12th :.:arch lSo9
ProfeGsor C, P* Ylen2.n^ ^
Dean of the faculty of Medicine^ 
University of Ulasgor/,
Ola ST CAN V/.
Dear Professor Pleieinao ?
Studies on the PpidenioloTy and 
Prevention of Ruhoila ___
I should like to sutnit the attached thesis 
for consideration for the degree cf IhD.
Acknowledgment has been made in the thesis 
to the help given by others^ but tho oz'-ganisation 
of the investigations desoribed^ tho analysis of 
tho results and the composition of ahe thesis have 
been done by ray self.
Ïours sine erely ^
A\ _ i'i S'
D* nead*
*
STUDIES 01 m B  EPIDMÏIOLOOY # D  PRlüOTTIOl 
OP RÜBELLà
by
Daniel Reid
H,D* Theeis submitted to the 
University of Glasgow
1969
G 0 M T E I $ s
J L O J d L Z ^ - J Ç  .
PABSa I s IB'ffiODüCIIOH
niunber
W M  I
1 THE MOKGEOüTO ATO ADÎS OE TUS THESIS 1BIT ||T|^fn«wipgi'Wii m i# iËf ' I# T'iiT— #T#iT#— wpiVn~<'^'i*~^*i'm  "~inir-ïTi— *Trf Trr~irnrt~'r~^ *'^ "rvTiTi r~ir~"imT~->~7 T^Tt
2 M  HISTQHIGAIi REVIEW 5
Early observations 5
Olinioal features and oomplioationa of 
rubella 8
Epidemiology, 12
Geographioal distribution 
Periodicity 
Seasonal behaviour 
Age distribution 
Sex incidence 
Incubation period
number
Teratogenic effects of rubella 16
Isolation and transmission of the
rubella virus 20
Immmity to rubella 21
Prevention of rubella 24
Passive immunisation 
Active immunisation 
Nummary of historical position 33
PAST II J m L B  STJJBIBS
G m m A L  PL#
number
4 A J M O M G lSa u S M ^ g S - J S @ £ L M  
M m ® a # S J O T J ® S W S L f f i
CffiASSLlïlLmÆSlàSI 42
Material and methods 
Results
m  Â B s m m m T  op the protectivio m a c T  
GomAOTs qp. R B E i m  imp m s  m m m
47
Material and methods
Measurement of the rubella 
antibody titres of various batches 
of immunoglobulin in current use 
for rubella prophylaxis
number
Estimation of the attaek rate 
of rubella among women who had 
been given immunoglobulin after 
contact with the disease while 
in the first four months of 
pregnancy-
Estimation of the attack rate 
of rubella among non-pregnant 
women of childbearing age in 
contact with the disease but not 
given immunoglobulin 
Results
A STUDY OF m m  IffiSGTîÛÜSŒS OF T Œ# m  uihptiiiig<Mic^'aEg«it*»iii>*tin-|wwriimBirrr
î'îaterlals and methods
Infectiousness of rubella 
Second attacks cf rubella 
ShbcliBical attacks of rubella 
Results
m
mimber
? UIBOUSBIOI 68
Immiuiity to rubella 
Protective effect of imraunoglobulin 
Attack rate of rubella 
Beoond attacks of rubella 
Olinical findings and isolation 
of the rubella virus
8 s?
9 S1®ARI 90
AOKSoi-mxaawrs 94
96
V O L U M E  II
Collection and handling of data
number
ill
Collection and transport of specimens
APPOTIK III
Laboratory methods 
I Serological tests
.Neutralisation test 
Haemagglutimtion-lnhibition test 
XI Virus isolation
Lomunoglobulin
APPMDXX y
Examples of protocols# record cards, punch 
cards, coding sheets,and standard letters,
TABLES AND FIGURES
Vlll
XX
P A R T  I
INTRODUCTION
###',1 • m  W  I 'H I » ^irlrlPtitf tfWf-
CHAPTER 1
TIIE BAGICgRQTMD ATO AIMS OF M
The olinical features of rubella have been recognised for at 
least three oentiiries without exciting much medical interest 
but during the last thirty years three major advances have 
completely changed our understanding of the opidemiology of 
the disease and the importance of its prevention,-
Firstly, in 1941 Dr. Norman H. Gregg recognised that a 
woman who developed rubella during early pregnancy was liable 
to give birth to a malformed infant. Secondly, it was realised 
that passive immunisation with either pooled plasma or human 
immunoglobulin (gemma globulin) might protect the pregnant 
mother who was in contact with a patient suffering from rubella 
during the period when foetal malformation was most, lilcely to 
occur, i.e. the first sixteen weeks after conception# As 
immunoglobulin is that fraction of the plasma containing antibody 
it was hoped that by immunisation of the mother, maternal 
viraemia would be prevented and, in turn, the developing foetus 
safeguarded# The increasing use of immunoglobulin gave rise to 
many investigations to determine its protective effect in 
pregnant rubella contacts. Thirdly, in 1962 the isolation of 
the rubella virus was reported (Weller and Neva, I9623 Parlman, 
Buesoher, and Artenstein, I962). This rapidly led to the
2 ,
establisiment of the laboratory diagnosis of rubella both 
by virus isolation and antibody titration. Prior to this, 
the study of the disease \\ras hampered by the mildness of the 
olinioal signs and the similarity of the features to those 
produced by other infections ; a confident diagnosis was 
therefore difficult* îfeiy patients could not reoall whether 
they had had rubella in the past, and, because of this, a 
previous history was not a reliable basis on which to distinguish 
persons susceptible to the disease (i.e* not previously infected) 
from those who possessed immmity* Moreover, subolinioal attacks 
could not be detected nor could the rubella antibody titres of 
different batches of immunoglobulin be estimated. After the 
discovery of the virus however, it became possible to détermine 
whether or not a person possessed antibody to rubella and to 
imdertake epidemiological studies to examine the infectiousness 
of the virus, the incidence of subolinioal, and of second attacks 
of rubella* The protection afforded by imunoglobulin, when 
given prophylactioally to pregnant contacts of the disease, 
could also be more accurately assessed because information on 
such factors as tlie susceptibility of the pregnant woman, the 
diagnosis of rubella in the patient with whom she was in contact, 
the development of infection (either olinioal or subolinioal) and 
the rubella antibody titre of the inummoglobulin could now bo
3#
obtained* In addition, the isolation of the rubella virus 
made possible the production of vaccines idiich should ultimately 
diminish the risk to pregnant women of developing the disease 
after contact with a case*
In the light of these laboratory advances the Public 
Health Laboratory Service in England and Wales set up a Working 
Party in December I965 to re-assess the protective effect of 
imimmoglobulin when given to contacts of rubella during the 
first sixteen weeks of pregnancy. As secretary of this Working 
Party I was responsible for the planning and organisation of 
the various epidemiological investigations and for the execution 
of much of the field work together with the ansilysis of the 
results. The majority of the investigations described in this 
thesis were made under the auspices of the Working Party but 
some were also conducted independently of it#
The aims of these studies were as follows s- 
1. To assess the proportion of women of childbearing age,
resident in different regions of the United ÎCingdom who 
possess antibody to rubella with special reference to 
their age-group, country of origin, previous history 
of rubella and obstetric experience#
2# To observe the differences in rubella, antibody titre of
the various batches of immunoglobulin which are in current
use In the United IClngdopj mià to determine, by means 
of a controlled trial, the prateotlve effect of 
teamoglobulija of high rubella antibody titro when 
given to oontaete of rubella who are within the firet 
sixteen weeks of pregnancy*
3* To study the iiifaotioiisaess of the rubella virus under 
various oiroumstsmees and to note tli© proportion of 
subolinioal and aeeond attacks of rubella tha-t oan be 
verified, by laboratory means*
Although several Investigations are deseribed in the 
thesis each is Intended to provide some information on the risk 
to persons, sapecially if in early pregnancy, when they are 
pxposed to the rubella virus and to determine the protection 
they may expect if given hmmnoglobulln,
Several aspects of these investigations have already 
been published elsewhere*^ In this thesis the material has 
been developed, extended and considered in relation to previous
StudJ.GS.
Bee attached reprints,
OIIAHL’ER 2
M  HISTORICAL EïïVIEl'/«3S
a) Early observations
The first description of rubella was probably made 
by Daniel Sennert of Wittenberg in I6I9 (Goodall, 1934)#
Ho considered that the disease, which ho termed Kitteln 
or Hotteln, was related to measles but was less dang’erous.
In 1676 James Cooke further emphasiaed the comparative 
mildness of the disease by referring to **rubeolae which 
happens to persons in health". Another early reference 
to rubella was quoted by Fuller (1730) from Peohlin (I671) 
who described "a small sort of Measles, cEilled Rothel which 
in his Travels he observed over-running the Palatinate and 
Bwabia sparing no Sex nor Age. Host of them had Restlessness, 
Lassitude, intense Heat, Loss of Appetite* Borne were confined 
two or three days to their Bed 3 some that were of foule 
Bodies, longer but some not at all* Upon talcing a Sudorific 
generally all went off easily and few dy’d of it* It was 
so rife and contagious that in the City of Btutgard seven 
hundred lay ill of it at once"*
During the eighteenth and nineteenth centuries many 
people did not consider rubella to be a separate disease*
6 .
Gnmer (1774) maintained that it was identical to scarlet 
fever while aooording to Hebra (1866) Bchonlein in 1832 
suggested that rubella possessed characters common to both 
soarlet fever and measles* This view was supported by 
Copland (1858) who noted that it was "doubtful whether or 
not this (rubella) should be viewed as a distinct or specific 
form of disease or merely a variety of either measles or 
soarlet fever in which many characters of either the one 
or the other predominate", and by Sir William Aitken (1864) 
who vrro-he "In truth it seems to be a hybrid disease developed 
from the combined poisons of the two fevers"*
Goiïimenoing with Selle (1788), who considered that 
"rubella is different from measles in that the fever does 
not present with bleariness of the eyes and oou^ing but 
for the most part with a stiff neck" the concept of a separate 
exanthem was gradually introduced. Farther evidence was 
given by Willan (1313) who described the disease as "rubeolao 
sine catarrhe" noting that patients suffering from this 
condition were "peculiarly liable to a second attack of 
measles" and two years later Maton, relating an outbrealc of 
rubella in London in a paper read before the Royal College 
of Physicians of London stated that "the period intervening 
between the application of the ini'ectious influence and the 
commencement of the disease was considerably longer then has
been noticed in scarlatina". Paterson (I840) describing 
the features of the disease as they presented among his 
patients in Leith, virote "that it possessesa characters 
peculiarly its omi". Despite this statement, however, it 
is likely that confusion with soarlet fever still existed 
as Paterson maintained in the sEime article, that sever© 
inflammation of the tonsils occurred and that the disease 
was "often an extremely and rapidly fatal disorder". 
Richardson (I867) also believed that rubella was a separate 
entity and thought that it was elicited by the irregular 
digestion of some particular form of food,
Thus by the mid-nineteenth century a large body of 
opinion considered rubella to be imrelated to either measles 
or soarlet fever. However the disease had to await the 
Seventh International Medical Congress of 1681 before it 
received general recognition as a separate disease.
While the controversy over the relationship of rubella 
to other diseases was continuing, much confusion was also 
caused by the different terminology. Bie early German 
workers used the names "Eitteln", "Rottoln" (BennertflGlg) 
and "Rotheln" (Pechlin, 1671)5 this last term was introduced 
into the United Kingdom by Paterson (I840).
During the eighteenth and nineteenth centuries, other 
physicians adopted different names for the disease*
8,
Belle (1788) used the term "rubeolao" and Bahington (I867) 
although differentiating the disease from measles, felt that 
there was suffioient resemblance to suggest the name 
"rubeola notha or bastard measles", Richardson (I867) 
further confused the situation by referring to "rosalia 
idiopathioa"• It m s  in 1866, however, that Henry Teale 
in a paper describing an outbrealc of the disease aaiong 
children and young' adults at the Mount Aboo Hill Station 
in the Presidenoy of Bombay suggested that "Rotheln is 
harsh and foreign to our ears" and that "Rubeola notha 
and Rosalia idiopathioa are too long for general use", He 
"ventured to propose Eubella as a substitute". This name 
wa,s not a new one as Richard Russel used it to describe 
"red gum" of infants in 1755 but after ¥eale’s suggestion 
it came to be accepted in Britain and the United States,- 
However, because of the early interest shorn in Germany, 
the disease was also commonly termed "Geriïm measles" in 
these countries,
b) Olinical features and ooHmlioations of rubella
The records of the nineteenth and early twentieth 
centuries indicated that rubella was a mild disease greatly 
overshadowed by the more lethal illnesses that were then 
prevalent and the least troublesome of the childiiood
9 .
infections (Maton, 18151 ¥ealô, 1866g Babington, 1867s 
Rolleston, 1937)* 0o trivial were the features of the 
disease considered that an editorial in the Edinburgh 
Medical Journal in 1940# celebrating the oentenacry of 
Paterson’s description of the disease, opened "German 
measles has been in the news of late and we hear of medical 
officers of health, headmasters, headmistresses, and others 
clamouring to have it deprived of *,#« its place as a 
notifiable disease and relegated to the limbo of the minor 
exanthemata »*.# a nuisance rather than an illness"* Were 
it not for Gregg’s discovery the following year of the 
teratogenic effects of the disease there is little doubt that 
rubella would, have continued to be regarded as trivial and 
self-limiting for as Dudgeon (1967a) points out, it is still 
a mild disease at least as far as the olinical features are 
concerned*
A detailed analysis of the signs and s^ iaptoms of 
rubella was made by Young and Ramsay in I963* They considered 
that the following features were important for the diagnosis 
to be made#
1. Mild prodromal symptoms with absence of coryza
but with injection of the tonsillo-pliaryngeal area 
associated with infection of the upper respiratory 
tract.
10,
2. Cervical lymph node enlargement with variable
involvement of the suboocipital Ijnnpii nodes.
5. Suffusion of the eyes, with the complaint of a
sensation of "grittiness” or even photophobia. ïhe 
authors oonsidered this to be a most irapox^ tant sign.
4* A macular-type rash appearing behind the ears, on
the face and rapidly spreading from above doimwards. 
She lesions become confluent and the erythema 
generalised giving a "peach bloom" appeeirance.
5* Occasionally petechial lesions on the palate.
In their series of 114 patients with rubella 94 
cent had iniÿîotion of the tonsillo-%)harangeal area, 97 pox' 
cent lymphadenojjathy, 85 per cent suffusion of the eyes, 
and 17 per cent palatal petechiae.
In hon-epidemic years when the disease is unexpected 
and because of the mildness of the physical signs, the 
diagnosis of rubella is difficult without laboratory help. 
The disease may be confused with measles, scarlet fever, 
toxic erythematous rashes of drug origin, infectious 
mononucleosis and E.O.E.O. virus infections. It is not 
surprising therefore that Young and Harnsay foimd that the 
illnesses in over 20 per oent of patients initially 
diagnosed as rubella were in fact due to other causes.
11 .
‘The oomplioatlons of rubella ere said to be rare 
(Kilbourne, 19^5) but while this appears to be true of 
children suffering from the disease there are several 
reports of adults being more troubled by the sequelae, 
l^y, Billane and Ery (19&2) noted that 11 of their 74 
adult patients with rubella complained of arthralgia with 
swelling of the joints# redness of the skin and pain on 
movement, line of these patients were women. Symptoms of 
compression of the median nerve in the carpal tunnel were 
also noted in tliree women. Gregg (1941) also mentioned 
that "an unusual number of young adult patients suffered 
from arthritis and other rheumatic conditions" after having 
had rubella,,»
Thrombocytopenic purpura has also been noted by several 
authors (Gimn# 1935§ Warren# Hogliand#and fotsubay# 194&; 
Green, Balsamo, Giles, ÎCrogman and Mlriok, 1965) usually 
just as the rash is fading. This complication may ;^esent . L 
with skin haemorrhages, epistaxis, bleeding from the gums or 
the gastro-intestinal tract. Purpura is seldom seen in other 
wise normal children (Dudgeon, 1967b).
A further complication of rubella is encephalitis. 
Mller, Stanton, and Gibbons (1956) reviewing 80 oases from 
the literature noted that the average time of onset of 
encephalitis was four days after the appearance of the rash.
1 2 .
Tiiey es‘bima,ted that the Incidence of this complication 
was one in 5,000 cases hut Pampiglione, Young, and 
Rmasay (1963) describing ten oases occurring during the 
1962-63 epidemic in the ïïnited Kingdom, suggested that 
encephalitis was more common. It is from this complication 
that death may occur and the mortality is high* Dudgeon 
(1967b) estimated that during the I962-63 epidemic, 20 per 
cent of the patients died within three days of developing 
encephalitis.
o) Mâffiâaisa 
(i) GgssæsÈlaii-JisMtoSIs»
Rubella has bean reported from nearly every 
country in the world (Wasselhoeft, 19471 Dudgeon, 1967b; 
Rubella Taocine Symposium, I968)* It is endemic in the large 
centres of population whereas in rural or isolated areas 
the disease may not recur for several years,' For example 
an outbreak of rubella took place in the Pribilof Islands in 
Alaska in 1940. It was not till I963 that the disease 
recurred when children, returning home from school on the 
mainland, brought the infection back to the community (33rody, 
Sevea?, McAlister, Sohiff, and Cutting, I965)*
(ii) Pe#o&foii^
In Gontrexst to the two year periodicity of measles
13.
xnxbella usually causes major epidemics every seven to 
nine years (Ingalls, Babbott, Hampson, and Gordon, I96O5 
Dudgeon, 1967b)* This cycle may be broken however, during 
times when large mmibers of persons are gathered together, 
Gregg (1941) mentioned that the epidemic which occurred in 
Australia in 1940 was particularly widespread and severe*'
At that time there must have been an increased opportunity 
for dissemination of the disease in view of the mobilisation 
in that country for the Second World War. Similarly, as 
Ingalls (1967) pointed out, rubella v/as endemic in the United 
States during 1951 and 1952 and again during 1963 and 1964; 
these periods coincide with the hostilities in Korea and Viet 
Ham*
(iii) Seasonal behaviour
Because rubella is not notifiable to the Registrar 
General it is difficult to accurately deterrmlne the seasonal 
behaviour of the disease in the United Kingdom, However, 
fifty general practitioners in practices so&ttered over 
Britain malce regular weekly returns of infectious diseases 
occurring in their patients to the Records Department of the 
Royal College of General Practitioners. The returns for 
rubella during I967 and I968 have been ara^anged in a 
diagramatio form in figures 1 and 2 and show that for these 
years the highest monthly incidence was in April and May
14.
but en Increased number of patients suffering from 
rubella was noted in January and the numbers did not 
markedly decrease till July, Kilbourne (1963) and 
'Ingalls (1967) believed that rubella is a disease of the > 
spring months but the figures of the Royal College of 
General Practitioners suggest that the disease is prevalent 
for a longer period in the United Kingdom and includes the 
latter half of the winter,
(iv) Age distribution
Most authors are agreed that rubella is rare in 
the first six months of life and in persons over 40 years 
of age. However, the disease has been reported in the 
newborn (McCracken, I963) and in a patient aged 82 years, 
(Simpson, 1940), There is some disagreement about the age 
at which the majority of infections occur*, Ingalls, 
Babbott, Hampson and Gordon (I96O) considered that children 
of school age had the highest incidence whereas Dudgeon 
(1967b) noted that the age-di s tribut ion of rubella had. 
changed du3?ing the past 60 years from being a disease of 
early childhood to one that chiefly affects young adults.
It may be that because of the reoogtiition of the ha%;ard of 
rubella in pregnancy, the increased severity of the compile, 
ations in older patients and the disruption caused by
15.
outbreelcs in institutions and among nurses and Service 
recruits, more attention is now paid to the disease when it 
occurs in young' adults.
(v) Bex incidence
\  f  Wf\ H» 'I'Ufi r~trT~fiii~*~i‘ nr r~ 1 ~rr "  n  riT 
Aycook and Dr^alls demonstrated in 1946 that up 
till the age of five years there is little difference in the 
attack rate of rubella between males and females but thereafter 
females are more likely to develop the disease than males.
This finding was confirmed in a survey undertal?;en in I965 
by the %idemic Observation Unit of the Royal College of 
General Practitioners ; in the childbearing period from 17 
to 44 years of age the attack x*at@ in women without a 
previous history of rubella was 5*5 per cent, but only 
0.6 per cent in men of the same age* This difference is 
presumably due to the closer contact of children with their 
mothers than their fathers but as mentioned in the report of 
the Royal College of General B^aotitioners the contrast is 
so considerable that possibly there is some other contributing 
factor.
(vi) Incubation period
As early as I8I5 Maton established tlial the 
incubation period of rubella was from 17 to 26 days and 
although most authors consider that it is usually I6 to 
18 days, there is agreement with the range given by Maton
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as extremes of 12 to 22 days (Dudgeon, 1967b) have been 
recorded.
In an experiment-donduoted by Anderson jxi 1949 
rubella was transmitted to human volunteers by spraying 
the naso-phaa^nageal 3?eglon with infected throat washings; 
the rash appeared I3 to 20 days aftenmrds although lymph- 
adenopatiiy could be detected after  ^to 6 days. This work 
has been repeated with almost identical results (Green, 
Balsamb, Giles, Krugimn, and Miriok, I965),
d) Teratogenic effects of rubella
Up till 1941 no trace can be found In the literature 
of evidence that rubella contracted during the course of 
pregnancy is responsible for foetal malformation. In that 
yesir, however, an unusually large number of patients with 
congenital cataract appeared in Sydney, Australia* Dr. lorman 
M. Greggg an ophthalmic surgeon noticed that this increased 
incidence of cataract occurred after a widespread epidemic 
of rubella the previous year# Gregg accordingly inquired 
closely, into the health during* their* pregnancies of the 
mothers of the affected infants* He foimd that in the 
majority, infection with emballa had occurred early in 
pregnancy usually dua7ing* the first or second months* After 
recovery the mothers had remained healthy till the birth 
of their babies. In his paper, "Congenital Cataract
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following German Measles in the Mother" given to the 
Ophthalmological Society of âustx'alia in 1941# Gregg 
recorded a series of 78 infants with congenita/i cataracts 
of whom 67 had a history of maternal rubella. The cataracts 
were often bilateral ajid 44 of the infants had also congenital 
defects of the heart of which patent ductus arteriosus was 
the most oommon. Mcrophthalmia was also frequently found 
and, in the retinae of several patients, irregular areas of 
pigmentation were present. The infants were often difficult 
to feed and appeared small and ill-nourished. Three years 
latex* Gregg described further patients in which the main 
defects were buphthalmoa and mental deficiency in addition 
to cataracts (Gregg, 1944)•
Gregg’s findings were soon confirmed by Swan and 
his colleagues (Swan, Tostevin, Moore, Mayo and Blaok, 1943? 
Swan, Tostevin and Black, 1946) and other Australian workers 
(Carruthers, 19431 Patrick, 194-G). Meanwhile, in many other 
parts of the world similar congenital defects after raatomal 
rubella were reported - in the United Kingdom by Simpson 
(1944)» Martin (1943, 1946) and by Olayton-Jones (1947)? 
in the United States by Reese (1944), Rones (1944), Erickson 
(1944) and Wesselhoeft (1949)? and in Switzerland by 
B ’cmcesohetti and Bourquin (1946)•-
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In addition to the classical ocular# hearing and 
cardiac defects which became Imoxm as the "rubella syiidx'ome" 
other congenital defects were later o'bsexved* Watson (1952) 
drew attention to the incidence of hepatosplenoraegaly and 
Lundstrom (1952, 1962) to microcephaly* Berge, Brunnlmge 
£uid Hilsson (1965) reported thrombocytopenia,.
Thus, by I963 a large amount of infommtion had been 
gathered about congenital defects caused by maternal rubella. 
However, much more Imowledge was soon to be gained as a 
widespread epidemic of rubella occurred in the United States 
of America between the end of I963 and the summer of I964 
in which 1,800,000 persons developed the disease (Sever, 
Helson, and Gillceson, I965)# Tlie additional features 
brought to light by this epidemic have been referred to as 
the "expanded rubella syndx'ome" or "acute disseminated 
rubella of the newborn".
A sujmiiaryr of the foetal defects now thought to be 
caused by infection with rubella during- early pregnancy is 
shovm in table 1.
Althougii Gregg’ was the first to note the teratogenic 
properties of the viams, descriptions of possible oases of 
congenital rubella, can be found in earlier literature. For 
instance, James War drop in 1815 published an account of 
the history of James Mitchel, ei boy born blind and deaf and
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in 1692 leuoh described a person suffering from pulmonary 
stenosis associated with deafness. Although the authors 
do hot refer to maternal rubella the lesions ax-e in keeping 
with a diagnosis of congenital rubella,
M£iny attOHipts have been made since 1941 to assess 
the inoidonoe of defects in infants born of mothers infected 
with rubella during the early months of pregnancy. Swan 
(1949) estimated from retrospective studies that 80 to 90 
per oent of such Infanta were malformed. Later prospective 
investigations however showed a much loifor proportion,,
Lundstrbm (1952, 19&2) found an incidence of 10.0 per cent 
in Sweden and in the United Kingdom during 1951*52, Hanson, 
Logan and Loy (196O) found that 15*8 per cent of children 
whose mothers had rubella during the first twelve weeks of 
pregnancy had malfonaations when examined at two years of 
age compared with 2,3 per oent in a control group. In 
addition there was an increased risk of abortion and stillbirth, 
Rubella contracted by the mother during the first 
month of pregnancy is more likely to produce a severe 
defect than in any of the subsequent months. Pitt and Keir 
(1965) studied IO5 children whose mothers developed rubella 
during the first 16 weeks of their pregnancies; they reported 
major defects in 60 per cent of children after infection in
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the first four weeks, in 33 cent after infection from 
the fifth to twelfth week and in 5*7 per oent from the 
thirteenth to the sixteenth week of gestation.
Dudgeon (I9670) oaloulated that after materna,! 
rubella during the first 16 weeks of pregnancy approximately 
30 to 35 por oent of foetuses were affected v;hen abortions 
and stillbirths were considered in addition to malformations,
e) Isolation and transmission of the rubella virus
Probably the first attempt to isolate the causative 
agent of rubella was made by Hess in I914. He undertook 
a bacteriological examination of the blood of infants 
suffering from the disease and also inoculated rhesus monkeys 
with these specimens. In no case, however, was an organism 
isolated and apart from a rise in temperature noted in one 
of the monlceys nineteen days after inoculation none of them 
was otheri'fise affected.
In 1938 Hire and Tasalca succeeded in transmitting 
the disease to children. They injected suboutaneously a 
filtrate of nasopharyngeal washings collected from patients 
during the px’oclromal stage of the disease and up to 30 hours 
after the appearance of the rash, into I6 children without 
a previous history of rubella. A rash developed in four of 
the children and two had cexvica,! lymphadenopathy without
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any skin eruption.
Habel (1942) attempted to grow the virus on the 
chorio-allantois of chick embryos and although no lésions 
developed he was able to infect rhesus moniceys with this 
material after five sub-eul.tureo • It has not been possible 
to confirm this work (Dudgeon# 1967b).
Twenty years were to elapse before the first 
successful isolations of the rubella virus were reported 
by workers in the United States, holler and Heva working 
at the Harvard School of Tropical Public Health# Boston, 
isolated the agent from the blood and urine of four patients 
suffering from, the disease by the inoculation of human skin- 
muscle tissue cultures and primary human anmion cultures; 
Parlcman, Buesoher and Artenstoin at the halter Reed Army 
Institute of Research# Washington, had similar success with 
material from the nasopharynx which they inoculated into 
px’imary African green monkey kidney cultures.
Within a short period of time isolation of the 
rubella virus became a standard procedure in many laboratories 
throughout the world,
f) Immunity to rubella
Shortly after the establishment of the laboratory 
diagnosis of rubella marjy advances were made in the understand" 
ing of the immunity to rubella. Studies in different
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GOîîîffiimities demonstrated that a large proportion of adult 
women possessed semm antibodies. Dudgeon (I965) noted 
that 84 per oent of women at a London obstetric hospital 
at the time of delivery# had antibody to rubella and 
Oxford (1966) found that the proportion was 76 per oent 
among pregnant women in the Sheffield ax’ea*. In similar 
studies in Canada (Givan, ICozee, and Rhodes, 1965) 80 per 
cent of the women examined possessed antibody and in the 
United States (Sever, Schiff, Bell, Kapikiaaa, Huebner, 
and Traub, I965) 85 per cent.
Because of the large number of persons with antibody 
to rubella it is difficult, at least in Britain and America, 
to demonstrate differences between communities. In a 
report to the Public Health Laboratory Service Rubella 
Working Party in I967 Hutchinson found that 85 per cent of 
seruun specimens obtained from around Leicester contained 
rubella antibody compared with 94 per oent of those from 
Manchester, Althougji the difference is not very impressive 
it may indicate that a person from a congested city is more 
likely to have antibody to rubella.
The possession of serum antibody is related to 
immunity. This was strikingly showi by Green, Balsamo,
Giles, Krugmmi and Miriok (I965) who attempted to infect 
children either by inoculation of serum obtained from patients
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with rubella or by ooniact with suoh patients* Of 
54 children who did not possess serum neutralising 
antibody in a dilution of 1 : 4# 46 (85, per oent) developed 
rubella, whereas all 37 children possessing antibody above 
this dilution were uniformly resistant to infection, 
regardless of the type of exposure. Moreover, susceptible 
individuals are usually devoid of antibody at the onset of 
infection and acquire it during convalescence.
The number of persons wdth serum antibodies found 
in the various communities is much greater than would be 
expected on the basis of a past history of clinical illness.
The reason for this probably lies in the fact that asymptomatic 
Infection is coiiMon. Horstmaim, Riordan, Ohtawmca and 
Miederman (I965) found the ratio of clinical to inapparent 
infection was approximately 1 to 1 but Buesoher (I965) put 
the ratio as high as 1 to 6 in a study he undertook in army 
recruits. This important finding tîirew light on such problems 
as the birth of babies with deformities typical of the rubella 
syndrome but whose mothers had apparently not had rubella 
during pregnancy. Avery, Monif, Sever and Leikin (1965) 
reported seven such instances.
As a result of the large proportion of adult women 
who are immune, most newborn infants are protected at birth 
and for the first few months of life by maternal antibody.
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By the sixth month of life this has usually disappeared 
and thereafter the incidence of antibody increases with 
age and the risk of exposure (Dudgeon, 1967b). Once 
acquired immunity appears to last for many years if not 
indefinitely. The study undertaîcen on the Rr^ibilof Islands 
(Brody, Sever, HcAlister, Sohiff and Gutting, I965) 
demonstra-ted that persons who had developed rubella 23 years 
previously were resistant to re-infection,
g) Prevention of rubella
Until the teratogenic properties of the rubella 
virus were recognised little effort ivas directed towards 
prevention of the disease. After 1941# however, energetic 
measures X'/ere taken in this direction.
Passive iiiamunisation after exposure with either
pooled plasma or immunoglobulin was the only available
means of attempting to prevent the disease until the rubella 
virus was isolated. This advance, however, made possible 
the production of live vaccines.
(i) Passive inimunisation
^  f ivnrrf-y-jr ~n— T— y -~t —^ " iT r - 'ir r rn r r fr r  i  ------— ‘
Humerous investigations have been carried out in 
various parts of the xvorld to try and determine the 
protective efficacy of pooled plasma or immunoglobulin when 
given to rubella contacts. The first recorded account of 
pooled plasma being u.sed in this way was given by Barenberg,
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Levy, Greenstein, and Greenberg in 1942» They injected 
intraTiiusculorly 30 ml, of pooled plasma to each of 
several children who xmre in a ward xfhere there xms 
Intimate contact and repeated exposure to imbella. Hone 
of the mnocu3.ated children developed the disease. The 
authors did not state the number of children who took part 
nor did they have a control group. Although this investig­
ation gave presumptive evidence of protection afforded by 
the pooled plasma the absence of a control group of uninooulated 
children made it difficult to know whether the disappearance 
of rubella was due to the administration of the plasma or to 
some other qiroumstanoe.
After this initial investigation a succession of 
studies to determine the value of immunoglobulin in contacts 
of rubella xmre made; the results indicated that this 
substance had also a protective effect (Korns, 19521 
Anderson and McLorinan, 1955? Houser and Bchalet, 1958;
Grayston and Watt on, 1959? Lundstrom, Thoren, and Blomquist,
1961).
More recently McDonald (19&3) in a controlled
investigation carried out s.t the Fountain Hospital, London, 
compared the incidence of the disease in a group of 94 
children selected at random who were each given 250 mg 
immunoglobulin and an uninoculated group of 89 children
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Xfho acted as controls. Hone of the children had a previous 
history of the disease hut all had been recently exposed to 
aTubella before inoculation* Sixteen developed rubella, 
including four children whose illnesses began within three 
days of the date of inoculation. Of the remainder only two 
(2.2 per cent) of the children given immtmoglobulin developed 
the disease compared with 10 (11.4 por cent) of the controls, 
thus suggesting that immunoglobulin had some protective 
effect.
Another? study demonstrating the proplaylaotic value 
of immunoglobulin was made in I964 by Brody# Sever and Sohiff 
in the Eskimo village of Barrow in Alaska. Rubella, had been 
absent from the area during the previous 12 years and after 
its introduction the disease spread rapidly in children of 
11 years of age and under. The epidemic began in December 
1963 and ceased three months later after involving at least 
69 of the 118 school children in the village. As the 
proportion of susceptible individuals xms Imrge a trial of 
inrniunoglobulin was carried out in the local school. After 
xfithdraxml of a blood sample 49 boys xfere given immunoglobulin 
(0.25 ml per pound bodyweight, anibella neutralising antibody 
titre !/; 512  ^ooncentra,tion not stated) and, on the assumption 
that it was better to allow girls to develop the disease to 
confer lasting immunity, they were left uninooulated to act
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as a control group. Records x^ ere then kept of the 
occurrence of rubella in the txm groups and also in I3 
males xfho had not been given immunoglobulin. Approximately 
one month later a second blood sample was talcen to detect 
rises in antibody titre. Before inoculation and for several 
days afteazwards, cases occurred in both male and female 
children at approximately equal rates. As the epideniio 
progressed, however, the excess of cases among girls became 
very apparent* Of 56 girls viho did not receive immunoglobulin 
50 (89 per cent) developed rubella compared with only 9 
(18 per cent ) of the 49 boys xfho x/ere inoculated. Of the 
affected boys five developed symptoms within six days of 
receiving immunoglobulin. Paired sera were available for 
35 girls and 45 boys. Glinical and serological results 
agreed in most eases but 15 of the boys given immunoglobulin 
and who did not later have rubella developed antibody, 
whereas none of the girls had a rise in titre without having 
had a rash. Thus the clinical signs of rubella in these 15 
boys were suppressed - probably by the immunoglobulin - 
although they were infected. Also of interest is the fact 
that a].though rubella virus was present in the conmaunity for 
at least a, month after the date of Inoculation there xms no 
increase in cases towards the end of this period among persons 
who received immunoglobulin# X'/hich suggests that the protective
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effect lasted for at least a month#
To assess the value of immtmoglohulin in pregnant 
contacts of rubella in the ïïnited Kingdom McDonald (1963) 
analysed the case records of 12,927 ’women who received 
immunoglobulin betx-reon 1954 and I96I. The attack rate 
within 28 days of exposure in the home after a dose of 
750 mg was 1*48 per cent and after I5OO mg, 1*13 por cent*
A complementary study by the Royal. College of General 
Practitioners (Watson and McDonald, I963) noted attack 
rates for uninooulated women of between 17 and 44 years of 
age after a family expos’ure to rubella of 5*7 per cent, or of 
5*5 per cent if xmmen with a past history of rubella were 
excluded#
In a later report which analysed the results of 
inoculation of 38,764 pregnant contacts of rubella with 
iîïmiimoglobulin during the years 1956 - 62, McDonald and 
Pecldaam (1967) showed that only 1*95 per cent of family 
contacts and 0*48 por cent of non-household contacts 
subsequently developed the disease*
These studies all suggest that immunoglobulin 
protects rubella contacts, but imfortunately there is other 
evidence that protection is sometimes lacking.
Green, Dalsmmo, Giles, Erugmaa and Mrick (I965) 
at the Willowbrook State School, Staten Island, Hew York,
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divided at random into two groups 70 children who were Imoxm 
to lack rubella imtibody* To one group they gave immuno­
globulin (0,12 - 0.20 ml/pound body xreight, ,rubella 
neutralising antibody titre to IX64# concentration not
stated) and the other group \mB left uninooulated. An attempt 
xms then made to infect the children xvith rubella by various 
means. Twenty xfere given an intraiauscular injection of serum 
containing rubella viarus and in 19 others the serum was 
sprayed on to the phaaynx. The remainder were exposed to 
the disease by contact xvith children xdio were already ill.
The children x^ rere then followed up to detect clinical and 
serological evidence of infection. Of the 33 children who were 
given immunoglobulin 27 (82 per cent) developed rubella,
18 (55 per cent) having; an illness with a rash; 34 (92 per 
cent) of the 37 uninooula.ted children became infected, 21 
(55 per cent) with a rash. Thus there was no evidence that 
immunoglobulin had any prophylactic value when given to 
contacts of rubella.
In 1963 Sohiff# Sever and ÏÏuebnea? suggested that 
the reason for the conflicting reports on the usefulness of 
immunoglobulin in the prevention of rubella was variation 
in the rubella antibody content of different batches. They 
fotmd that there was an eight-fold difference in rubella 
neutralising antibody (256 to 2048) in 19 samples of
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Anierioan immunoglobulin which they tested, Oxford (1966) 
noted a sima.lar disparity in antibody titre between 
immimogiobulixx of Dutch and British manufacture - the latter 
gave consistently higher rubella antibody titres,
McDonald (1963) considered that the time of 
administration of immunoglobulin in relation to the contact’s 
exposure to the infection might also be a factor in 
determining protections the attack ra/be in home contacts 
was less if the injection were delayed till the fifth day 
after exposure when the immunoglobulin might be more 
effective in control of the viraeniic phase of the illness*
A :further explsuiation of the disappointing results 
vras given by Mm?phy and Reid (I967) xMio thought that as 
antibod,ies to immunoglobulin may be formed after previous 
therapy (Stiehm and Fudenberg# 1965) these may neutralise 
the effect of a future prophylactic dose.
It is clear tha>t despite the niunber of studies 
confusion still exists on the value of hmmnoglobulin in 
preventing rubella. Although several of the investigations 
were uncontrolled and carried out before laboratory assistance 
was available# it is difficult to disregæ?d the work of Brody, 
Sever and Schiff (I965) that gave convincing evidence of the 
value of immunoglobulin, nor theequal3y convincing study of 
Green and his colleagues (1965) who showed that it did not
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prevent rubella, l#iatever the explanation# none of the 
Investigations that were controlled and complemented by 
serum antibody- titrations# gave oxsy information about the 
prob'l^ B of protection of the rubella contact who is in 
early pregnancy? this of course is the vital issue.
(ii) Active imsiunisation
# 1iiSIV6ass»Vtix^8«<V"ei!?e*ttACxrî*ï«ae.'tiKp!eeytïr-ii6^**aexixv*'*Feî,7î4."ttïtw •
The isolation of the rubella virus# the better 
understanding of the causal relationship between maternal 
rubella and congenital abnormality, the uncertain benefit 
of passive ijmnunisatioii against rubella and the births of 
large numbers of deforîBed infants after the rubella epidemic 
of 1963*64 in the United States gave new stimulus to efforts 
to develop some form of active imnunisation against this 
disease* Formerly many authorities advocated the deliberate 
exposure of young girls to rubella in the hope that they 
would become infected and so develop natural immimity. This 
procedure ha,s its dangers in that further spread of the disease 
cannot be readily controlled and, since many infections are 
mild or subclinical, the virus may D?each women in early 
pregnancy (Lancet# I966).
The first attempts to produce a live rubella virus 
va.Gcine we:re reported in I966 (Parkman, Meyer, Kirschstein 
and Hopps# I966; Meyer# Parkmsn# and Parios, i960). The
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strain of rubella virus that they used was attenuated 
by 77 passages in prinmry African green moiAcey kidney cell 
cultures, This strain# designated ïïPT-77 (high passage 
virus) produoèd an antibody response in 68 to $6 per oent 
of susceptible children (Oooper# Giles, and Krugman, I9681 
Meyer, Parkman, Hobbins and Ennis, I966? Lepow, Yeronelli, 
l-ostetlev, and Robbins, 1968), Glinical rubella and 
viraemia were not noted in the children who received the 
vaccine and despite the fact that rubella virus could be 
recovered from the nasophax’ynx of 50 to 70 per cent of vaccin* 
ated children there was no spread of infection to susceptible 
contacts,
Although the vaccine did not evoke as great an 
antibody response as after the natural disease, the titre 
was sufficient to protect against subsequent infection,
Five girls who had been vaccinated eight months to one year 
previously with HPT-77 were challenged intranasally with 
natux'al rubella virn^ s (Meyer, Paxioae^ , Hobbins and Ennis, 
1968)* Hone developed clinical or virological evidence of 
rubella. By contrast a control group of five unvaccinated 
susceptible girds all developed lymphadenopathy and three 
had a rash; on the twentyfirst day of illness rubella 
antibody wa,s detected in all these unvaccinated girls.
Thirty vaccinated persons in this study have now’- been
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followed for a year and the rubella antibody induced by 
Tacoination is still stable#
One potential hasard of a live rubella virus 
vaccine is of affecting the foetus if the mother were 
vaccinated d.uring early pregnancy# Preliminary experimental 
work in pregnant monlceys (Parîcman, Meyer# Hopps# and 
Kirschstein# 1967} showed tha;t the attenuated virus does 
not cross the placental barrier# A more recent study in 
which pregnant woiien without antibody to rubella were 
vaccinated up to two weeks before undergoing a therapeutic 
abortion# failed to demonstrate that the virus had been 
trahsferred to the foetus (l\ix"iilcawa# I968). The numbers 
taking part in this investigation were small, however, and 
in view of the importance of determining- the teratogenicity 
of the attenuated rubella virus this point requires further 
scrutiny,
h'i Summarv of the historical position to date
(i) After at least two centuries of confusion with 
measles and scarlet fever x’libella is now estE^blished as a 
disea,se in its own right#
(ii) Although the clinical features are well recognised 
it may be difficult on physical exarriination to distinguish 
it from other diseases; it is therefore still misdiagnosed.
34.
(ill) Rubella has a world-wide distribution and
epidemics occur every seven to nine years; most cases have 
been noted in April and î^lay,
(iv) The teratogenic effect of rubella contracted by 
the mother during the first four months of pregnancy has 
been confirmed by many studies,
(v) Rubella is caused by a virus, the isolation of which 
rapidly led torelii^ blLe diagnostic procedures,
(vi) Over 80 per cent of adult women in Europe and the 
United States have been found to possess rubella antibody,
(vii) Despite several investigations into the prophylactic 
effect of immunoglobulin, the value of this substance is still 
in doubt,
(viii) Studies with live-attenuated rubella vaccine have 
shorn that it evokes an antibody response which is protective 
and that the attenuated virus does not spread to susceptible 
contacts.
P A R O' II
FISLI) STUDIES
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This chapter describes only in outline the different 
field studies that were undertalcen and shows the way in 
which each contributed to the evaluation of inmunoglobulin 
vjhen given to pregnant rubella contacts#
Although the investigations were complementary 
it appeared logical to descxlbe them separately with the 
results obtained* Thus each of the following three chapters 
gives an account of the procedures adopted for each study 
and reports on the findings. An account of the collection 
and handling of the data, laboratory methods aîid examples of 
protocols and record cards az^ e given in the appendices*.
In most of the investigations the virological 
examination of specimens was performed in the Public Health 
Laboratories at Bedford, Bristol, Garmarthen, Oolindale, 
Coventry, Leeds, Liverpool, Manchester and Newcastle* As 
facilities were available at these laboratories the field 
studies were usually carried out in adjacent areas*
Because of the evidence that persons who have 
acquired antibody to rubella are resistant to reinfection 
with the rubella virus (Green, Balsajno, Giles, Krugman, and 
Miricic, 1965) a, survey was undertalcen to determine the
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serum rubella antibody titres among women of childbearing 
age and so estimate the proportion at risk to infection.
The relationship of the participant’s antibody titre to the 
locality in which she lived, age, place of origin, history 
of previous illnesses diagnosed as rubella, number of 
previous. pregnancies, siiscax'riages and stillbirths were noted* 
It was believed that an initial investigation of 
this kind was necessary to form a foundation on which to 
base the subsequent studies.
To assess the prophylactic value of immunoglobulin 
given to women in the first four months of pregnancy because 
of recent contact with rubella it was considered important 
to determine three factss
(i) the attack rate of rubella among pregnant contacts
of the disease who had been given immnoglobulin ;
(ii) the rubella antibody titres of the immunoglobulin 
used;
(ill) the attack rate of rubella among an adequate control
group.
In England and Wales when a doctor is consulted 
by a patient in early p3?egnanoy who has recently been in 
contact with a person suffering from rubella, he may obtain 
a supp3.y of immunoglobulin from the nearest Public Health
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Laboratory, Advantage was taken of this standard procédure 
to arrange for the collection, of paired blood samples from 
pregnant rubella contacts, the first sample being taken 
immediately before administering the inmmioglobulin mid 
the second six weeks later* By comparing the antibody 
titres in the two samples it was possible to determine if 
infection had taken place. In addition the doctor was 
asked to ta3.ce swabs from the throat and nose of the person 
who was suffering from rubella (the index case) so that the 
diagnosis could be confirmed by virus isolation,
To enable the prophylactic value of immunoglobulin 
to be assessed without the suspicion that any failux*e to 
protect Blight have been due to low rubella antibody titres 
in the batches used, samples talcen from immunoglobulin 
issued from the manufacturers during the period of the 
investigation were titrated. Based on this information 
stocks of immunoglobulin of high rubella antibody titre 
were reserved for the study. In addition it was possible to 
observe the range of rubella antibody titres in the batches 
of immunoglobulin in current use.
In an ideal controlled Investigation the pregnant 
rubella contacts would have been divided into two groups 
by random allocation and one group given immunoglobulin but
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not the other. This prooedure could not be followed 
for ethical reasons since there was previous evidence that 
immunoglobulin nii^t protect the foetus.. It was decided 
that the control group that came closest to the ideal 
comprised women of childbearing age who were in contact 
with rubella but who were not pregnant and so did not 
require protection. For this purpose doctors working in 
general practice were invited to send paired serum samples 
from non-pregnant rubella contacts and nose and throat swabs 
from the index cases. Thus the only differences between the 
inoculated and control groups were that one group consisted 
of pregnant women ^ yen immunoglobulin and the other of 
non-pregnant women not given immunoglobulin.
To determine the infectiousness of the rubella, virus 
under different circumstances the following factors were 
consideredI
(i) the attack rate of rubella after exposure to
the disease in the home;
(ii) the attack rate after exposure outside the home;
(iii) the attack rate after exposure in a semi-
residential community.
The risk of infection inside and outside the home 
among contacts was calculated from the information obtained
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during the investigation to determine the prophyiaotio 
value of immunoglobulin*
An opportunity to study the risk among contacts 
of patients suffering from rubella in a semi-residential 
oommmity arose when an outbrealc occurred at a Police Training 
College* As with the previous studies paired blood samples 
were withdrami from the contacts of the patients suffering 
from rubella and titrated for rubella antibody to determine 
the nimber who became infected.
These various investigations also gave information on 
the influence of the sex of the oontact on the susceptibility 
to infection with the rubella virus. Similarly in female 
Gontaots it was possible to determine if pregnancy altered the 
susceptibility*
Because all the inquiries described in this thesis were 
based on laboratory as well as clinical findings it was possible 
to compare the attack rate of rubella determined on serological 
studies with that on clinical grounds and so estimate the 
frequency with which subolinica,! infections occurred*
Moreover, the incidence of subclinioal infection 
among the women given immunoglobulin was compared with the 
incidence among the uninoculated control groups ; in this 
way the question of whether immunoglobulin acts merely by
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Biippressing the çlinical features of the disease rather 
than hy preventing actual infeotion, was exajnined*
Since an attack of rubella results in the formation 
of antibody that is long lasting (Brody, Sever, McAlister.i' 
Schiff and Gutting, 19^5) it imy be inferred that the 
presence of rubella antibody reflects previous, but not 
necessarily recent, infection and that persons who lack 
antibody are unlikely to have had rubella in the past. The 
frequency of second attacks of rubella could therefore be 
assessed by notirg the number of persons who already possessed 
antibody and had a further rise in titre after contact with 
rubellai,
In summary, tliree linlced investigations were designed 
to examine the various points raised in this thesis :
(i) a serological survey of adult females not recently
in contact with rubella;
(ii) a comparison of the attack rate of rubella aiBong
women who had been given immunoglobulin after 
contact with the disease while in the first four 
months of pregnancy, with an uninoculated control 
groupi
(iii) % study of the spread of rubella in a semi-
residential community.
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Because these Investigations were conducted in 
various parts of the United Kingdom and involved many 
people - laboratory workers and doctors in general practice - 
it was necessary to have standard methods# These will be 
described in detail in the succeeding chapters but in general 
the following procedure was common to all the investigations.
Protocols describing the organisation of the studies 
and standard record cards were designed and distributed. 
Suitable specimen sets for taking throat and nose swabs and 
blood from patients were also sent to doctors. In addition 
control sera were issued to the pax‘ticipating laboratories 
to ensure that the serological results were uniform.
Until October I967 the serum rubella antibody 
titres wore determined by the neutralisation test. During 
the remainder of the investigation the haeraaggiutination- 
inliibition (H.A.I.) test was used exclusively as it was found 
to be more sensitive, less time-consuming, and gave comparable 
results (Field, Yandervelde, Thompson mid Hutchinson, I967). 
For this investigation serum neutralising titres greater than 
1 t 4 o;od haemagglutination-ihhibiting titres grea-ter than 
1 s 8 were regarded as indicative of imiunity to rubella* 
l/hen completed the record cards were returned to 
the Epidemiological Research Laboratory, Oolindale, London, 
where they were checked, coded and analysed.
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CHâEtER 4
A SEROLOGICAL SmVET TO RÜBELLA . OI' ADULT mM&LES 
MOT HEOSfnY IM COMTAOT WITH THE DISEASE
Material and Methods
Tills survey to determine the proportion of women who 
possess antibody to rubella started in January I966 and was 
completed in November 19&7* Ten areas in England and Wales - 
Bedford, Bristol, Garmarthen, Coventry, Keighley, Leeds,
Liverpool, London, ï-îenohester and Hewoastle - were involved 
so that geographical differences in semm antibody titres could 
be examined;
As it was intended to study women mainly of childbearing 
age, obstetricians in charge of ante-natal clinics were approached 
and arrangements made for the collection of about 2 ml. of venous 
blood at the time other samples routine.ly required during early 
pregnancy were obtained. Samples from older women were provided 
by other hospital departments.
A protocol describing the methods to be used and standard 
record cards (form I3) were distributed to the doctors taking* 
part. The card recorded the following information) participant’s 
name, address, na;bionality, age, possible history of rubella and 
date of infection, number of pregnancies, miscarriages and 
stillbirths and rubella antibody titre. Eboh card was stamped
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with a number to identify the woman and the region in which she 
livedo Provision was made on the card for coding the information* 
Ibcamples of the protocol and record card are shoxm in the
appendix (pages sii).
The record card was usually completed immediately before
the blood sample was taken* VJhere this was not possible, the
informa/bion was extracted from the patient’s case sheet*
Blood samples were either dispatched directly to the
local Public Health Laboratory or stored in a refrigerator at 
o44 0 until transport was arranged.
Rubella antibody titrations were carried out by means 
of the serum neutralisation test (page Titres were
entered on to the record cards which were then sent to the 
Epidemiological Research Laboratory for analysis.
Results
A total of 2,007 blood samples were collected from 
ten different areas of England and Wales* Table 2 shows the 
antibody titres of the sera according to area* Because of the 
proximity of Leeds and Keighley the results have been combined*
Of the total, 184 (9 per cent) with titres less than 1 : 4 
were regarded as susceptible and 1,779 (89 per cent) with titres 
of 1 3 8 or greater as immune due to past infection* In the 
small number 44 (2 per cent) with titres of Is^î- the results
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have been regarded as eqtiivooa3. as it is doubtful if a titre 
of this sise is real evidence of past infection and probably 
represents non-specific "viral inhibition in the neutralisation 
test*
Tiie proportion of women susceptible to rubella varied 
in the different areas ranging from 20 per cent in the London 
area to 4 po3? cent in Leeds* This difference was statistically 
Significant (x^ « 50*86, P <0.00l). Coventry (5 per cent), 
Bedford (8 per cent) and Manchester (9 per cent) also had a low 
proportion of susceptible women. Taking all areas into consid­
eration an average of 9 per cent of women of childbeailng age 
were susceptible*
The rubella neutralising antibody titres found in the 
different age groups are shorn in table 3 end figure 3* The 
age groups covered five-year periods from 15 to 45 years* l*he 
proportion susceptible fell from 16 per cent in those between 
15 and 19 years of age to 1 per cent in those over 40 years* 
This difference was statistically significant (x 28.2,
P < 0*001) but there was little change in the proportion 
susceptible in the age groups between 20 and 59 years*
Of the women investigated, 220 (ll per cent) caaiie from 
countries outside the United Kingdom; West Indians contributed 
35 per cent of this total, Indians and PaJcistanis 20 per cent, 
Europeans 14 per cent and Africans 7 per cent (table 4). The
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European^ ^ Indian and Palcistani women had a similar proportion 
susceptible to rubella as British women. However, West Indian 
and African women had a hi^ier proportion. Although the British 
group was much larger than the West Indian or African groups, 
the difference between the proportion susceptible was 
statistically significant = 25*12, P <0.001)*
The history of a previous attack of rubella, was examined 
in relation to the presence of neutralising antibody (table 5)*
Of the 545 i)articipants vfho remembered having had an attack of 
rubella- only 5 pen cent lacked antibody compared with 12 per cent 
of the 1,100 who denied previous illness and 9 per cent of those 
who did not know* Again this difference was statistically 
significant (x*“ « 20.23, F <0.00l).
To examine whether women with large farailies would be 
more likely to possess immunity to rubella because of the 
increased risk of contact with an infected child, antibody 
titres, according to the parity of the woman are shorn in table 6. 
Apart from the high proportion (29 per cent) of susceptible women 
among the small group who had never been pregnant, there was 
little difference in the distribution of antibody titres between 
the various groups. The difference did not attain statistical 
significance a,t the one per cent level (x^  == 7*25, 0,02 > P <0.05).
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Of the participants 413, (20 per cent) had a history 
of miscarriage or stillbirth* The distribution of the serum 
neutralising antibody titres according to the number of 
miscarriages or stillbirths reported is recorded in table 7*
Tiiere was little variation in the titres between the different 
groups; women who had previously had a miscarriage or stillbirth 
were as likely to be susceptible to rubella as those without 
such a history.
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CHAPTER 5
M  ASSBSSMT OE THE PROTECTIVE EEITICT OP_IMt*ÎOÎ(OGLOBÏÏI)IN 
\fflEB GIVHÎ TO OOMfflACTS OF RUBELLA W O  ARE WITHIH THE 
FIRST SIXTESM WEEKS OF HîEGMAHCY$#*]È^A#w^3«fN?kr=*M \a i\w "44:;]A:»:éaiJucA:an'a^A*AKPŒ3#5B»ïab f i#minTP4)Wi^3=Lz5Ezi%M:W!aR*ü»A4kt.Lfv,tç^a
Materials and methods 
Tlie three linked studies considered necessaary for the 
adequate evaluation of the prop|iylactic effect of imuno- 
globulin when given to pregrnant rubella contacts are 
described in this chapter. The period of the investigation 
ims from December@ I965 to December, I968,
(i) Measurement of the rubella, antibody titres of 
various batches of iimunoglobuljn in
Although most of the immunoglobulin Issued in England 
and Wales is manufactured by the Lister Institute of Preventive 
Medicine, Elstree, Hertfordshire, it is distributed to 
practitioners by laboratories of the Public Health Laboratory 
Service which are supplied from a centmal stock held at the 
Epidemiological Research Laboratory, As the material usually 
spends some time at the Epidemiological Research Laboratoiy 
before distribution to the other laboratories the opportunity 
was taken to have samples of I5 batches issued by the Lister
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institute betimen December I965 and July 1968 titrated 
for rubella, antibody, Mb,ch batch wa,s recently prepared and 
had at least tv/o years till the date of expiry* The 
titrations were performed at the Virus Reference Laboratory, 
Oolindale5 using the rubella neutralisation test.
five batches of immunoglobulin were reserved for the 
pregnant rubella contacts who participated in the investigation. 
Two of these batches had rubella neutralising titres of 1 ; g20 
(LKG 123 and LEG I3I); the remainder had titres of 1 s 120 
(LEG 127, LEG 138 and LEG I4I).
(ii) Estimation of the attack rate ofrabella
ifith the disease while in the first four months of
This enquiry was conducted in areas of England and 
Wales served by the following Public Health Laboratories : 
Bedford, Bristol, Garmarthen, Oolindale, County Hall (London), 
Croydon, Coventry, Epsom, Exeter, Ipswich, Leeds, Liverpool, 
Newcastle, Horthallerton, Nottingham, Oxford, Peterborough, 
Portsmouth, Salisbury, Sunderland, Swansea, Taunton and 
Winchester*
A protocol outlining the standard methods to be used 
and record cards (Pregnant Contact Record Card (l), Pregnant 
Contact Record Card (2), Index Case Record Gard) were
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d-lstributed to all ooncemed* jStcamples of the protocol and 
record cards are shorn in the appendix (pages xxi, xxiii).
In addition, at least one visit was paid to participating 
laboratory directors so that difficulties could be discussed 
and a uniform policy arranged.
Each record card was stamped with a serial number to 
identify the patient, general practitioner and issuing' 
laboratory.
To facilitate the transport of specimens from the 
general practitioner to the laboratory, special packs were 
designed (see page xvi) that contained the following' items:- 
1# One detailed instruction sheet (page
2. One McCartney bottle (-^ fluid bs.) for collection 
of the blood sample.
3. Two sterile swabsticks (throat mid nose).
4* Two bijoux bottles containing virus transport 
medium (page^^ )*
5* Two cardboard containers in which the McCartney 
and bijoux bottles were placed.
6. One leak-proof padded envelope.
7# One numbered Pregnant Contact Record Card (l).
8. One Index Case Record Card*
9* One pre-paid label for retxîrn of the specimens*
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A stock of these items and a supply of immunoglobulin 
taken from the reserved batches were despatched to the various 
laboratory directors involved for issue to general 
practitioners *
The procedure at participating laboratories was as 
follows : when a practitioner requested immunoglobulin for 
a woman in the first four months of pregnancy who had been in 
recent contact with a patient suffering from rubella, he was 
told of the investigation and, if he agreed to take part, a 
pack including an ampoule containing 750 mg. immunoglobulin 
taken from the reserved batch, wa,s sent to him#
On receipt of the pack, the doctor arranged to collect 
between 2 and 5 ml. of venous blood from the pregnant rubella 
oontact, injected the immunoglobulin intramuscularly and 
entered the relevant clinical details on the Pregnant Oontact 
Record Card (l).
t/hen possible, and particularly when the source of 
rubella was a member of the same household, the doctor was also 
asked to talce throat and nasal swabs from the index case. The 
swabs were immediately dipped into the virus transport medium 
contained in the tvjo bijoux bottles. The doctor then completed 
the Index Case Record Card giving clinical details of the case 
of rubella. Because many of these patients were young children,
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blood saJûfiples were not routinely collected from them.
Specimens were sent by the quickest available means 
(usually by post) to the laboratory designated to carry out 
the virological examinations •
If there were any delay in sending specimens the doctor 
was asked either to keep them at t4^G (i.e. usually in a 
domestic refrigerator) until suitable transport could be 
arranged or else to send the blood samples to the nearest 
Public Health Laboratory for separation of the serum and onward 
transmission to the appropriate centre*
Six weeks after the first blood sample was obtained, 
or sooner if it had been taken some time after the date of the 
pregnant womancontact with the index case of rubella, a 
second pack containing a HoOartney bottle, cardboard container, 
standard record card (Pregnant Contact Record Card (2) ) and 
pre-paid label was sent to the doctor with a request for a 
further specimen of blood from his patient* The doctor was also 
asked to state whether or not the patient had developed the 
olinical signs of the disease. If the second specimen were not 
received at the laborator^^ a reminder was sent about a month 
later;
Until Octoberj 196?s second blood samples were requested 
for all contacts who had given a first sample in order to 
detersiine the proportion of contacts suffering from second attacks
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of rubella. By this time, hoimver, it was considered that 
a stdrficient mmber of paired specimens had been collected from 
those who were already iimune. Thereafter the collection of 
second blood samples was restricted to those who wore initially 
susceptible.
Also in October I967 it ifas decided to increase the dose 
of immunoglobulin given to a home contact of rubella to 
determine if this reduced the attack rate* The initial dose was 
increased to 1,500 mg. In addition a further 1,500 mg. was sent 
to the contact’s doctor if the first blood sample had a 
haemagglutination-inhibiting titre of 1 s 8 or less; the second 
dose was only sent if it could be given before the end of the 
incubation period# Thus ideally a susceptible home contact 
of rubella in early pregnancy was given four times the standard 
dose (750 mg# ) of i&miunoglobiilin during the latter period of 
the investigation#
I'lien the antibody titre or the result of the examination 
of throat and nose swabs for rubella virus was Imown, a report 
sent to the patient’s doctor and a copy to the director of 
the laboratory that issued the immunoglobulin# The titres and 
isolation results were also entered on the record cards which were 
then sent to the Epidemiological Research Laboratory for checking, 
coding and analysis.
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(iii) Estimation of the attack rate of rubella among
non-pre^ant women of childbearing in contact
with the disease but not given immunoglobulin
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So that the results could be compared, this study
was conducted during cfchei same period of time as that to 
determine the attack rate of rubella in pregnant contacts 
given immunoglobulin.
A detailed protocol and record cards (Oontact Record 
Card (l), Contact Record Card (2), and Index Case Record Card) 
were distributed to all the persons concerned in the project*
The cards were similar in design to those used in the study
ooncex*ned with the pregnant rubella contacts* libcamples of the
protocol and cards are shot-m in the appendix (pages xxviii to xxxiii). 
A pack was also produced resembling that already described 
(page 4 9) except that the ampoule of immunoglobulin was omitted*
Seventy-one general practitioners in England and Wales 
and %n?ee in Scotland were contacted, most with the help of the 
Epidemic Observation Unit of the Royal College of General 
Practitioners, and invited to pæ.licipate. At least one 
personal visit was made to ^1 of the doctors to explain the 
prooedu37e* Detailed instructions were sent to the others by 
post*
Each practitioner who agreed to take part was sent twenty
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sets of cards and packs# A further supply was despatched 
as required# The doctor was asked to taice swabs from the 
throat and nose of any patient whom he suspected on clinical 
grounds to he suffering from rubella* He was a3.so requested to 
obtain between 2 and 5 ml# of venous blood from any women of 
childbearing age (i#e. between 15 to 45 years) who were not 
pregnant but who were members of the same household as the 
index case* These specimens were sent to the appropriate 
laboratory where rubella virus isolation was attempted and 
antibody titrations performed# 8ixty-twp of the doctors 
found it easier to send the swabs and blood by post to the 
Virus Reference Laboratory ett Colindale; the remainder 
delivered their specimens to the nearest participating 
laboratory* A report on the findings was returned to the 
doctor who sent the specimen*
If the rubella antibody titre in the first blood sample 
indicated that the contact was susceptible to rubella, a second 
sample was requested six weeks later to determine whether or 
not she had become infected. The doctor m s  asked to record 
any clinical signs of rubella that developed in the contact.
The rubella antibody titre of this second blood sample 
was also sent to the doctor from the laboratory and the results 
entered on the record cards#
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To augment the number of women participating in this 
control group, each general practitioner who submitted 
specimens for the investigation involving pregnant rubella 
contacts (page 4B ) was requested by letter (page xxxvli) 
to provide suitable samples from non-pregnant contacts of 
rubella. A total of 379 doctors were contacted in this way.
Results«LESKLTKCKmSÏVarwr^
(i)
The rubella neutralising antibody titrer of the 15 
batches of immunoglobulin submitted for titration is shovrn in 
table 8. It was reported from the laboratory that difficulty 
was experienced in obtaining a definite rubella antibody end­
point and because of this the titres of antibody are expressed 
as the highest dilution that substantially neutralised the virus*
Each batch contained rubella neutralising antibody, the 
titres ranging from 1 s 60 to 1 $ 320* A titre of 1 : 120 was 
found in seven of the batches*
(ii)
Of the 1747 pregnant women who were given 750 mg, of 
immunoglobulin after contact with a patient suffering- from 
rubella (diagnosed on clinical grounds and irrespective of viral 
isolation) 1483 (85 per cent) already possessed antibody to 
rubella* This figure is similar to that found in the serological
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survey i(table 2)* Among the 264 women who lacked antibody
Î
and who|were therefore susceptible to the disease 46 (17 per 
cent) d||veloped serological evidence of infection (i.e* a 
foiir-fold or greater rise in antibody titre) in the second 
blood sample despite having had izmmmoglob-ul in * A olinical 
illness with a rash was present in 24 (52 per cent) of these 
women and the remainder had a subclinioal infection (table 9 
and figure 4)#
The index case was a member of the same household as 
28 of the susceptible pregnant contacts who developed rubella; 
Of these women, I4 developed clinical illness and I4 had sub- 
clinical infections (table 10)* Of the 18 patients who were 
infected outside the home, 10 developed a rash and eight were 
subolinioally infected*
The clinical diagnosis was confirmed by the isolation of 
rubella virus from 126 index cases (table 11 ). The number of 
susceptible pregnant contacts of these cases was 25 (20 per 
cent) and 14 (56 per cent) of these developed rubella, 11 
clinically and three subolinioally*
jxi 75 instances where the index case was a member of 
the same household as the pregnant woman, I5 (20 per cent) 
of the women were still susceptible* Of these, 12 (80 per cent) 
subsequently becax/ie infected, nine clinically and three sub-
57.
cliîiioally (table 12, figure 5).
Contact outside the home with a proved case of rubella 
oocurred in 51 instances and 10 of the women were susceptible*
Of these only two became infected; both had illnesses with a 
rash* This difference in attack rate between susceptible 
pregnant women in contact within the home and. those outside is 
significant at the 5 por cent level ( P < 0,05)#
The time interval between the date of onset of the rash 
in the index case, inoculation of the pregnant contact with 
immunoglobulin and development of the rash in the 14 susceptible 
contacts of provèd rubella who became Infected is shown in 
figure 6* Three of the 14 women were inoculated on the day the 
index case developed the rash and 7 others ■ received globulin 
within three days of the, rash appearing in the index case.
In the nine inoculated women who developed a rash after 
home contact with a confirmed case of rubella, the interval 
between the onset of the rash in the index case and the maternal 
rash ranged from 11 to 23 days (table 13). The interval was 
between 16 and 18 days in five of these nine women.
Among a further subgroup of 62 susceptible women in 
%diom six cases of rubella developed (one olinical and five sub- 
clinical )virus isolation from the index ease, although attempted, 
was unsuccessful* This may have been explained by the fant that
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the throat and nose swabs were not colleoted until four to 
10 days after the onset of illness#
The age distribution of the 1747 pregnant women who were 
given Immunoglobulin after contact with rubella is shoim in 
table 14; 1544 (88 per cent) were aged between 20 and 34
years of age# In the various age groups between 80 and 96 per 
cent of these women possessed antibody and, as found in the 
serological siW!^y, older women wore less likely to be 
susceptible#
Table 15 gives the results of the attack rate in the 
separate group of 57 susceptible women who were given two 
divided doses of hmimoglobulin, each of 1500 mg, after home 
contact with a case of rubella* Of these women 14 (24 per cent) 
developed rubella, seven having an illness with a rash# However, 
six of the women were in oontact with a patient from whom 
rubella virus was isolated; four* of these six women developed 
rubella, all with a rash.
(iii) Oonteol RTOttp
Five hundred and forty-three women froBi various parts of 
the United Kingdom were included in this aspect of the investig­
ation and 493 (91 per cent) possessed antibody to rubella v;hen 
©xaïïdned (table 16, figure 7)« All the index cases were members 
of the same household as the uninooulated contacts. Of the 50
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women without antibody in contact with index cases diagnosed 
as rubella on clinical grounds 18 (5^ per cent) developed the 
disease (16 clinically and two subolinically) *
Bitbella virus was isolated from 208 of the index oases 
but 182 (87 per cent) of their contacts alread^  ^possessed 
antibody (table 17 figure 8), Of the 26 women who were 
susceptible 15 (5^ per cent) subsequently developed rubella 
(11 clinically and two subolinioally)#
For these 11 vjomea who developed a rash after contact with 
a confirmed case of rubella» the interval between the dates of 
onset of their rash is related to that in the index case in 
table 18* îhis interval ranged from 10 to 26 days; for six 
of the 11 women the Interval was between 16 and 21 days#
Table 19 gives the age distribution of the 545 women 
in the control group| 57^ (6g per cent) were aged between 20
and 54 years# The proportion of women who possessed antibody 
ranged from 68 to 97 por cent*
(iv)
InforiTiation was provided for 874 index oases in the 
inoculated and control groups* The clinical features of these 
patients are sliom in table 20* A rash was recorded in 97 
per cent; lymphadenopatby in 82 per cent* fever in 6l per cent 
and arthritis in g per cent of patients*
Rubella virus was isolated from 554 (59 ps^ r cent) of the
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848 patients with a rash (table 21)# For the first tliree 
days after the onset of the rash the vlrma was isolated from 
between 49 and 55 per cent of the patients; thereafter the 
proportion of swabs that were positive dropped to between 25 
and 50 per cent up to the sixth day after the onset of the 
rash* Only seldom was an isolation obtained after this time.
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CMCTEH 6
A Sl'TOY Qg fllB IHEBCJIOÏÏSHESS OF THB ROBBLLft rJHÏÏS 
AWDJKE PEOPORTIOS OP SEOOHD AHD STOOLHflCAL IHEECTOTS
THAT IT PfiOBUGES
Material and Methods
(i) ,Infeotiouenegs of rubella
In January 1960 an outbrealc of rubella occurred at the 
Metropolitan Police Training College» Hendon, London. Ac the 
cadets spend at least six months at the Training College, 
working closely together in classrooms and sleeping in dormitories 
this seemed an ideal opportunity to study the spread of the 
disease in a oomunity.
The initial cases were Isolated at the Metropolitan Police 
Hursing Home, Denmark Hill, London. The nursing home was 
visited, the patients examined and clinical details recorded? 
swabs were taken from the nose and throat and blood samples 
obtained. The specimens were sent iîmaediately to the Virus 
Reference Laborator^r for attempted virus isolation and antibody 
titration. Repeat blood samples were collected fteom the same 
patients four weeks later.
After the first visit to the nursing home arrangements 
were made with the officer in charge of the training college for
the cadets In the same training section as those affected 
to he bled to determine the number who were still susceptible 
to rubella* The blood samples were rapidly screened by means of 
the haemagglutination^-^inhibition test and those cadets found 
to be susceptible were observed to determine if clinical 
disease ocoisrredo â second blood sample m s  taken from 
susceptible cadets about six weeks after the first*
The clinical details, rubella antibody titrations and 
virus isolations were entered on record cards and the results 
analysed by hand.
(ii) gecpnd attacks of rubella
Between December I965 and October 196? paired sera were 
collected from the women participating in the investigation to 
determine the proph^ ’^laotic effect of immunoglobulin when given 
to pregnant rubella contacts, irrespective of whether antibody 
ivas present in the first sample*
To determine the proportion of second attacks of rubella 
a search was made for woBien who had pre-existing antibody but 
who developed a further attack of the illness*
As many index cases vrho have illnesses resembling 
rubella on clinical grounds are, in fact, suffering from 
diseases caused by other viruses, the study was oonfineddto 
women in contact with an index case from whom rubella was 
isolated.
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(ill) Subollnic^l attaoks of rubella
file fregiiency with which inapparent rubella infections 
occurred and the question of whether imumoglobulin acts by 
suppressing the clinical features of the disease or by preventing 
iïifection, tfere investigated by means of the following procedure* 
a,) Examination of the records of women participating
in the serological survey (peige 42) to determine the 
proportion who possessed antibody to rubella, but who 
did not give a history of having had the clinical 
manifestations of the disease*
b) Hoting the number of uninoculated contacts in the
control group in the study to assess the value of 
immunoglobulin (page 5§)and of those talcing part in 
the police cadet study (page 6I) who developed 
serological evidence of infection, but who did not 
have the signs and symptoms of rubella*
c) Determination of the number of subclinioal attacks
in pregnant rubella contacts given immunoglobulin*
Results.Mum
(i) Infectiousness of rubella
Between the l6th of January mid the 20th of February, 
i960, 17 cases of rubella occurred at the Metropolitan Police 
Training College; 13 of these developed during the last four 
days of this period (figure 9).
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Sv/abs from the throat and nose and paired blood samples 
were obtained from these 13 cadets. Rubella virus was isolated 
from tlirea of them and a four^fold rise in rubella antibody 
titre in one. The difficulty in confirming the clinical 
diagcxoses in every cadet is explained by the fact that there 
was a delay of from two to five days between the onset of 
the rash and the date of the specimens being talcen*
Rubella antibody titration of the blood samples taken 
from the remaining 224 cadets in the same training section as 
the oases revealed that 217 (97 por cent) already possessed 
antibody.
The cadets were recruited from many parts of the British 
Isles (table 22 and figure 10) although 162 (72 per cent) came 
fro3B London and the Home Counties. Because of the small number 
of persons who were susceptible it was not possible to demonstrate 
if there was any geographical influence on susceptibility*
Of the seven cadets found to lack antibody, all developed 
serological evidence of rubella and six had an illness with a 
rash (table 25). Details of these cases are given in table 24*
(ii) Second attacks of rubella
Between December, 1965 and October, I967 there were 106 
women (84 pregnant and 22 not pregnant) taking part in the study 
of the assessment of immunoglobulin (page 47) possessed
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rubella neutralising antibody greater than 1 s 4 or haemag- 
glutination inhibiting antibody greater than 1 t 8 £md who 
were in contact with confirmed index oases of rubella 
(table 25)*
Of these women only one pregnant mother developed a 
possible second attack of rubella# She was in contact with 
her son who had typical rubella with a rash, enlargement of 
the posterior cervical lymph nodes and fever# Rubella virus 
was gromi from a nasal swab talcen from the son on the day 
following the onset of the ra.sh# As the mother was 10 weeks* 
pregnant at the time of her son*s illness a blood sample was 
taken and she was given 750 mg. immunoglobulin intramuscularly. 
The rubella neutralising antibody titre of this batch of 
immunoglobixlin was 1 ; 320. 'Share was a delay of only one 
day between the onset of the sonis rash and the date of the blood 
saiïiple and inoculation of the mother. Fifteen days after the 
onset of the son’s rash, however, the Biother developed a 
rubelliform rash and rubella virus was isolated from a throat 
swab talcen from her at the time of the rash# A second specimen 
of her blood obtained four weeks later showed that the neutralis­
ing antibo#' titre was almost unchanged (l s 24 iu the first 
specimen and 1 : 32 in the second), This result probably lies 
within the limits of the error of the test as the titres
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obtained by the complementixation test reDiainêdi? stationary 
at 1 8 l6 as did those demonstrated by the haemaggXxitination.^ 
inhibition test at 1 t 256 but the isolation of imbella vimxs 
from the mother suggests that this was indeed a second attack*
In none of the 106 women studied did a four^fold increase in 
the antibody titre occur although 14 showed an eqiiivooal 
variation*
(iii) 0ubelinioal attacks. of ^rubells.
The frequency of subclinical attacks was estimated 
from the following evidence*
Of 2,007 women examined in the rubella antibody survey 
(page 4^) 1,100 (55 per cent) stated that they had not 
experienced a previous clinical attack of rubella (table 5)*
Only 157 (15 per cent) of these 1,100 women had rubella 
neutralising antibody of 1 2 4 or less* Thus the remaining 
943 women either had had a subclinioal attack of rubella or 
their meBioxy of the illness was at fault. Although it is likely 
that many would have forgotten having rubella since infections 
probably occurred in childhood, it seems reasonable to suppose 
that in a proportion the discrepaixcy between past history and 
serological findings VJae due to subclinioal infection*
Better evidence was found in the study to determine the 
attack rate of rubella in the control group of non-pregnant 
rubella contacts (page 53) Of the 543 contacts, IS developed
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rubella oonfirjBed serologically# Only two (11 per cent) 
developed a four-fold or greater rise in rubella antibody 
titre but did not have any of the dinioal features of 
rubella (table 16)* Also in the police cadet study only one 
patient of the seven who developed rubella, had a subclinioal 
infection (table 23).
Of the 46 pregnant rubella contacts given immnoglobulin 
and who later developed rubella, 22 had a subclinioal infection 
(table 9) whereas only two of the 18 oases in the control group 
were infected without having a rash (table 16), This difference 
is statistically si^ifioant (x ~ 5*9» F < 0,02 ) 0*01).
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m soïïssioi
Rubella is a particularly difficult disease to study 
without laboratory help* The clinical illness is usually 
vague and fleeting and liable to be confused with other 
conditions* The isolation of the rubella virus in I962 
and the introduction of the laboratory diagnosis was therefore 
a very important development especially in view of the 
teratogenic properties of the virus.
Before this major advance, it had been definitely 
established that rubella is infectious, produces signs and 
symptoms which are usually mild and frequently causes foetal 
abnormality when contracted by women in early pregnancy* These 
facts are still undisputed#
However, there was also considerable evidence that 
immunoglobulin exerted a protective effect when given to pregnant 
rubella contacts* This evidence was obtained by observing the 
proportion of women given immunoglobulin after contact with 
rubella who did not develop the clinical features of the disease. 
Tiie early workers were neither able to confirm the diagnosis, nor 
to determine if the person were already immune to rubella before 
contact. Because the presence of antibody has been shovjn to
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protect against infection with rubella (Green, Balsamo, Giles, 
Krugman and Hiriok, 1965) immunoglobulin given to contacts of 
1 the disease who already possessed antibody was almost bound to 
be"successful". To adequately assess the protective effect 
afforded by immmoglobulin given to pregnant women after contact 
with rubella it is necessary to confine the investigation to 
susceptible women in contact with confirmed oases of the 
disease. A suitable control group consisting of.uninoculated 
women in similar circumstances is also required.. Tîierefore a 
reliable assessment of immunoglobulin could not talce place before 
laboratory help was available because information on the suscept­
ibility of the contact and the confirmation of the diagnosis 
could hot be obtained by other means.
By 1965# however, isolation of the rubella virus and 
determination of the rubella antibody titre was sufficiently 
well established to regard the laboratory' diagnosis of infection 
as reliable. It was therefore possible to enquire into these 
problems on a much sounder basis than had hitherto been possible.
The proportion of immune persons in the populations 
involved in the various aspects of this investigation was found 
to be consistently high - 89 per cent in the survey of adult women 
not in recent contact with rubella (table 2)§ 85 per cent of
pregnant contacts of rubella (table 9); 91 per cent of the
70*
control group of non-prognant women (table 16) and 97 per 
cent of the cadets involved in the training school outbreak 
(table 23). These high proportions of persons already 
immune are similar to others published which range from 
76 to 84 per cent (Dudgeon, 1965; Given » Kosee» and Rhodes,
19651 Sever, Schiff, Bell, Kapikian, Huebner, and Traub, 19655 
Oxford, 1966),
Some degree of variation in the percentage of women 
immune to rubella was noted between the populations in the 
various regions studied# The area with the largest percentage 
of immune women was that drmw from around Leeds and Keighley#
Here $6 per cent of the women tested possessed antibody to 
rubella. It is surprising that the other northern cities taking 
part - Newcastle, Manchester and Liverpool - did not have 
similar results but the difference is almost certainly due to
a.true geographical variation and not a difference in laboratory 
teclinique in view of the standardisation of procedures that took 
place at the beginning of the investigation (see appendix, page v)# 
Because most of the blood samples obtained for this survey 
came from women attending ante-natal clinics in various towns 
and cities, the proportion of immune persons is possibly larger 
than if rural areas were studied# This may not in fact be the 
case however, as Field (196?) noted that 95 per cent of the 
inhabitants of a rural village in Wales possessed rubella
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antibody at the time of examination.
Aa ffii^ t be expected because of the persistence of 
rubella antibody after infection (Brody, Sever, McAlister,
Schiff, and Cutting, 1965) there were more susceptible persons 
in the younger than in the older age groups. The proportion of 
those susceptible fell from 16 per cent in women under 20 years 
old to less than 10 per cent in older persons* Only 1 per cent 
of those over 40 y^ars of age were suscei^tible (table 3). Thus 
the risk of developing the disease after contact is higher in 
young persons although even in those under 20, the majority were 
already immune.
Eleven per cent of those studied in the survey came from 
outside the ïïnited Kingdom (table 4)# The proportion of European, 
Indian and Pakistani women who were immune was similar to that 
found in British women. The West Indian and African communities 
on the other hand had a lower proportion of imimme women. This 
difference was statistically significant and it is possible that 
there is a racial susceptibility to rubella. ’ The number in these 
groups however, was too small to come to any firm conclusion*
Before it was possible to determine serologically whether 
a person possessed rubella antibody or not, reliance in detecting' 
immunity had to be placed on the memory of a previous attack 
of the disease. On comparing the rubella antibody possessed by 
a patient with her memory of a previous clinical attack (table 5)
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this method of determining immunity is shown to he highly 
unreliablei Fortunately the error is usually to assume that 
a person is not immune when in fact she does possess antibody. 
Only 5 per cent of the women tfho stated that they had contracted 
rubella in the past did not have rubella antibody. Of those who 
denied a previous attack of rubella, however, only 12 per cent 
kaoked antibody, a pointer to the possible high rate of sub- 
clinical illness.
A susceptible woman is at greater risk of contracting 
rubella inside her home, usually from one of her children, than 
she is from contact outside (table 12). It is, therefore, not 
surprising that the proportion of women with antibody was hi^er 
in those with children (table 6), probably because the usualj 
nurse of a child with rubella is its mother. It could also be 
argued that wosien without a family may have a different social 
background and live in a less crowded neighbourhood that those 
with several children; these women may not therefore have had 
the same opportunity to contract the disease.
Apart from foetal malformations about five per cent of 
mothers who develop rubella during the first 12 weeks of 
pregnancy have miscarria^?es or stillbirths as compared with about 
two per cent in a cont3?ol group of healthy mothers (Hanson,
Logan and Loy, I960), nineteen per cent of the women taking 
part in the rubella antibody survey had one or more miscarriages
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or stillbirths prior to the investigation (table 7). The 
proportion of these women who possessed antibody to rubella, 
however, was only slightly higher than the proportion in 
those who had a better obstetric history* Ttils failure to 
demonstrate a difference between the groups is probably due to 
the fact that the total number of women in the survey who were 
susceptible was small#
Beoause the majority of persons in the ïïnited Kingdom 
possess antibody to rubella and as immunoglobulin is prepared 
from pools of plasma obtained from adult donors, it follows that 
British immunoglobulin is likely to contain rubella antibody*
The results given in table 8 verify that all the batches 
examined contained antibody so that it is unlikely the manufact­
uring process affects the antibody titre to any large extent#
Immunoglobulin has been used in the ïïnited Kingdom since 
1954 for the protection of women in contact with rubella during 
early pregnancy# Various reports on its propliylactic value 
have been given (McDonald, 19&3; Brody, Sever, and Schiff,
19655 Green, Balsamo, Giles, Krugman, and Mriok, 1965). As 
recently as I967, McDonald and BeoMiam, in an analysis of 30,764 
pregnancies complicated by contact with rubella, suggested that 
a degree of protection was given by imniunoglobulin. The field
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w r k  of the investigation, however, was completed in 1962 
and because of this, virologioal studies were not carried out. 
These workers therefore, were unable to take into aooount the 
large number of women who were already immme before immuno­
globulin was given, those developing a subclinioal attack, and 
those in contact with diseases other than rubella.
To avoid these sources of error» every woman who 
participated in the present studies was screened for the presence 
of rubella antibody. VJhen only susceptible women were considered, 
irrespective of whether the illness in the index case was always 
true rubella, I7 per cent of the pregnant rubella contacts 
given the standard dose of 750 mg. immunoglobulin developed 
serologically proved rubella (table 9). With the further 
restriction of confirmation of rubella in the index case by 
virus isolation, 56 per cent of susceptible pregnant contacts 
became infected (table 11). It was also noted that of the 15 
susceptible women in contact with a proved case of rubella who 
was also a member of the same household, IS (80 per cent) 
subsequently developed the disease even when they were inoculated 
early in the incubation period (table 12, figure 6). This 
illustrates that the extremely high attack rate among susceptible 
pregnant contacts can only be revealed by considering' separately 
those women in contact with a proved case of rubella in the 
home where there is a high likelihood of spread of infection.
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if Immune contacts mze not excluded from the analysis 
and if no aooount is taken of the number of contacts who 
develop subclinioal attacks of rubella then the true position 
is obscured. Thus only 24 pregnant women out of a total of 
1747 in contact with rubella actually developed a clinical 
illness with a rash, an attack rate of only I.4 por cent 
(table 9). This is very similar to the attack rate of 1.2 
per cent found by McDonald and Peokham (I967) and on this basis 
one could perhaps have thought that immunoglobulin exerted a 
protective effect*
In addition to the consideration of the attack rate of 
rubella among contacts given immunoglobulin, it was particularly 
important to have a control group in this investigation* The 
numerous factors already mentioned that determine the proportion 
of women who become infected (e.g. percentage of women with 
pre-existing antibody, closeness of contact with the index case, 
and accuracy of diagnosis of the illness in the index case) may 
influence the result quite apart from the effect of immunoglobulin* 
The control group used was not ideal - they were not 
pregnant and althou#i all of childbearing age, the women were 
slightly older (tables 14 and 19). Despite these limitations 
the comparison of the attack rates between the groups did not 
suggest that immunoglobulin at the dosage used m s  giving any 
protection to the pregnant contacts.
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SHfO factors may have been present to give such poor 
results - sisse of the dose and time of administration*
a) Dose
. .Brody, Sever» and Schiff (1965) demonstrated that 
immmoglobulin was protective when given to rubella contacts.
As their investigation included antibody studies, subclinioal 
attacks were unlikely to have been missed and the number of 
izmmme persons in the population was knoim. Also there was an 
adequate control group. Brody however» gave a much higher dose 
of imiunoglobu].in than that normally used in the United îCingdom* 
He injected an amount dependent on the weight of the individual -
0.25 ml per pound body weight. Although he did not state the 
concentration of immunoglobulin it was presumably that normally 
issued to American contacts, i.e. 16 per cant. This dose, if 
given to a woman weiring 9 stone, would amount to approximately
4,500 mg. - six times larger than the standard British dose* 
McDonald (I965) found that the attack rate in pregnant 
rubella contacts varied between 1*48 per cent after a dose of 
750 mg. immunoglobulin and 1.15 per cent after 1,500 mg. The 
difference, however, was not statistically significant (P = O.l).
Additional evidence that a larger dose of immunoglobulin 
may give better results was put forward by members of the Public 
Health Laboratory Service Working Party on Rubella (1968a) who 
showed that circulating rubella antibody v/as not observed in
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susceptible women after a 750 mg* injection of immunoglobulin, 
whereas low antibody titres were obtained in those given
1,500 mg; a divided dose of 3,000 mg. resulted in detectable 
antibody for 12 weeks.
Despite these encouraging reports, I4 (24 per cent) of 
57 susceptible p3?egnant home contacts of rubella in the present 
study developed the disease even although they had received
3,000 mg. of immunoglobulin (table 15). \1hen the analysis is 
limited to the six susceptible women in contact with confirmed 
oases of rubella,, four developed rubella,
b) Time of administration
Usually the first warning a pregnant mother gets of the 
presence of rubella in a person with whom she has been in 
contact, is the appearance of a rash. However, most cases are 
probably Infectious before this as Green, Balsamo, Giles, ICrugman, 
and Mriok (19^5 ) isolated the virus from the naso-pliaryngeal 
secretions of cases up to seven days before the rash appear*ed. 
Thus, even if immunoglobulin is given to the mother promptly 
after the appearance of the rash in the index case, she herself 
may well be incubating the disease by this time.
In this current investigation the interval between the 
date of onset of the rash in the index case and that in the 
contact was under 16 days in three of the inoculated women 
(table 13) and four of the controls (table 18) who developed
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rubella. These intervals sizggest that the contact became 
infected before the index case developed the rash.
A report by the Public Health Laboratory Service (1968b) 
on the propjriylaxls of infectious hepatitis demonstrated the 
advantage of giving immunoglobulin as early in the incubation 
period as possible* TMs may also apply in the prevention of 
rubella* However, Green and his colleagues (1965) in their 
series of experiments, varied the time of administration of 
immunoglobulin from between five days before exposure to rubella 
to 24 hours after exposure* Ho protective effect vras noted 
with any of these regimes, and the time of administration of 
immunoglobulin was considerably earlier than can be given in 
practioe to a pregnant rubella contact*
A further difficulty that arises when immunoglobulin 
is used propliylaotically in rubella is that it may suppress the 
clinical features of the disease but not prevent infection*
The proportion of subclinioal infections in inoculated women 
who developed rubella was 48 cent (table 9) whereas only 
11 per cent of the infected controls had a subclinical illness 
(table 16). Tliis effect of immmoglobulin has already been 
demonstrated by Ward and Krugman (1962) in the prophylaxis of 
infectious hepatitis. They showed that the number of clinical 
cases of infectious hepatitis among contacts was substantially 
reduced after inoculation but the attack rate as measmzed by
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abnormal liver funotion tests was unaffected.
Although Horstmam (lg68) suggested that in subolinieal 
infections the duration of viraemia and the virus dose to the 
foetus is probably decreased» she admitted that babies with the 
rubella syndrome may be b o m  to mothers v;ho do not give a history 
of rash or other clinical manifestation of rubella* The degree 
of risk to the foetus from maternal subelinical infection 
requires further study but this type of infection is also 
dangerous for two reasonss first» the ziiother may be lulled into 
a false sense of security if serological studies are not 
performed after immunoglobulin has been given and the infection 
is not detected; second, if she has become infected and is 
unaware of it, she may spread the virus to other individuals - 
especially other pregnant women with whom she comes into contact, 
e#g. at an ante-natal clinic* Evidence that subolinieal cases 
mze likely to be infectious has been given by several workers 
experimenting with rubella vaccine (Cooper, Giles and Krugman, 
I96S1 Lepow, Teronellij Hostetler, and Bobbins, I9681 Meyer, 
Farkman, Hobbins and Ennis, I968). They found that susceptible 
persons given the vaccine, imdemmnt serological conversion 
and excreted the virus but did not develop the clinical features 
of the disease*
A susceptible pregnant woman in contact with a case of 
confirmed rubella in her ovm home can expect therefore little
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protection from the close of immunoglobulin currently offered*
It is -unlikely that this sit-uation can be greatly improved 
until rubella vaccines become generally available, The larger 
dose of 3,000' mg. of immunoglobulin :lnves'bigated in the present 
study represents a large (20 ml) and painful injection. Moreover, 
immunoglobixlin is in short supply in the ïïnited Kingdom, a 
considerable quantity having to be imported from Eeonch, Swiss 
and Dutch sources* It is also expensive ^ one 750 mg* ampoule 
costs £1, 7* 0* (Department of Health and Social Security, 1968)* 
To give the dose that Brody found to be protective would cost 
£8* 2* 0* for each contact and as the volume of thisedose of 
immunoglobulin would amount 'bo over 30 ml* it would require 
several injections.
If massive doses ware considered the demand could be 
eased if immunoglobulin were, given only to those found to be 
susceptible* Over 80 per cent of women in the United Kingdom 
already possess rubella antibody and they are unlikely to require 
further protection in view of the small number of second attacks 
of the disease that occur (page 64)* The difficulty, however, 
is separating immune from, the susoeptlble contacts early enough 
so that the latter may be injected with a larger dose* The 
haemagglutination-inhibition and fluorescent antibody tests are 
likely to be some help in this direction as with these, it is 
possible to get a result within tiro days* However, by this time
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the patient May he well into the inoiihation period as there 
is delay - aToidahle and miavoidable at every stages from 
the time the pregnant mother notices the patient’s rash until 
she goes to he?3 general practitioner p in sending a blood sample 
to the appropriate laboratory for antibody titration; in 
getting the result back to the doctor and sending him a supply 
of injiiïunoglobulini until the patient returns to the doctor for 
the dmmmoglobulin which may require» if a large dose is given, 
several injections over a nmîber of days*
A further difficulty is that some of the cases in 
contact with pregnant mothers may well be subclinioal and 
therefore go undeteoted, as virologloal studies would normally 
only be oarried out if the index case happened to be pregnant.
Probably the only satisfactory way to ensure that 
susceptible women in the first four months of pregnancy get 
a large amount of immmoglobulin quickly enough is to determine 
their immunity before the^ ' are in contact with the disease*,- 
This would require mass screening of women to assess their 
rubella antibody status irrospeotive of their previous history 
of olinioal illness. Those found to be susceptible could then 
present themselves for inoculation as soon after contact as 
possible and not have to wait for the result of an antibody 
titration. Broder  ^Sever and Schiff (1965 ) considered that for 
ïïiaxiBïam protection it might be wise to administer immunoglobulin
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to women considered at risk (e.g. nurses and teachers) even 
before a knovm eicposure to rubella has occurred.
As already diecuBsed a pregnant woman is much more 
at risk from a member of her own family - usually one of her 
children - than from an outside contact. Possibly therefore 
the best time to test her seruiü for rubella antibody is when 
she is pregnant for the first time.. Tills is because it is 
likely to be this child who may at a later date izifect her 
with rubella when she is pregnant again. Apart from this^ 
the timing is convenient as she will usually- have a blood sample 
taken during this period in any case for such things as blood 
grouping* and haemoglobulin estimation.
The cost of a soreening procedure is oonsiderable. An 
estimate for staffing and equipx>ing one laboratory has been made 
by Tobin (lg66). He has calculated the initial price to be in 
the a^ egion of £5,000 but such a laboratory could serve a large 
area of the coimtry and it would not be necessary to renew the 
equipment yearly. In comparison, immumoglobuXin costs the 
United Kingdom annually about £25,000 when 750 mg. is given 
to pregnant rubella contacts on request. If Brody be dosag*e 
level is adopted the cost would be £150,000 annually and at 
least 80 per cent of this would be wasted because of the 
proportion of immune women.
Thus if the use of inmunoglobulin is to continue there
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is little doubt that by far the most economical method of 
attempting to protect pregnant women from the rubella virus 
until a rubella vaccine is available, is to separate out those 
who are susceptible and give them very large doses of immuno­
globulin immediately after or preferably just before they 
are in contact with a patient suffering from the disease*
Apart from economic grounds, this Method is more likely to be 
successful in protecting the foetus*
Another approach to the problem is to carry out serological 
tests for rubella antibodies before pregnancy and offer a 
therapeutic abortion to those found to be susceptible and who 
subsequently develop rubella during the first four months of 
pregnancy (Ross, I968)* Horstmaim (1968) supports this view and 
suggests that immunoglobulin is reserved for women who, because 
of religious and other grounds, reib.se to have the pregnancy 
terminated. Certainly on the present evidence a susceptible 
pregnant woman in contact with rubella cannot be reassured after 
an injection of immunoglobulin.
Attack rate of r^ubella
Ihe attack rate in susceptible women in close contact 
with confirmed rubella was 50 per cent in the uninoculated 
controls (table 17) and 80 per cent in those who were pregnant 
and given immunoglobulin (table 12). Although not statistically
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aijgnil'iaaâîi (%' = 0,8, ? € tliia finding' sng’gests
tliat auBoeptibilitÿ* to rubella magr be altered by pregnanoy,
M  inoreased sueoeptibility to paralytic poliori^elitic in 
pregnant women hae been noted provioi^ly (Siegel and Greenberg, 
1955)? presumably this is due to hormonal changes é tChere is 
an increased level of 17 hydro^yoortioosteroids in the blood 
during pregnancy (Gemsoll, 1955) and Venning (194&) also 
observed that the urinary ezoretion of corticosteroids is 
increased during the first trimester of pregnancy. Steroid 
hormones are known to inhibit initiation of the antibody 
response (British Medical Journal, 1966) and persons talcing 
corticosteroids are especially prone to severe attacks of other 
viral diseases euoh as olxiekenpox (Haggerty and Bley, 1956 g 
Johnson and Nelson, i960),
ïhe attack rate aaaong the police cadets was 100 per cent. 
Although the number of susceptible persons was small in this 
investigation it would appear that the lower attack rates 
previously noted among males as compmzed with females (Royal 
College of General Practitioners, 1963) was probably due to 
lack of exposure rather than a decreased susceptibility to rubella, 
Second atta^ cks of rubella
Only one woman in this investigation developed a second 
attack of rubella although for nearly tim years paired sera
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were taken from m  many rubella oontaots as possible,
immune and ausoeptible, in search of a rise in titre.
It would appear therefore that in the majority of 
oases a previous attack of rubella confers protection for at 
least a considerable period of time, fhis finding has been 
previously reported several times (Sever, Scbiff, and îraub,
19621 Buescher, I965J Green, Balsamo, Giles, Erugman, and 
l^ îirick, 1965g Eorstmaim, Eiordan, Ohtawara, and Niederman,I965; 
Plotkin, Gornfeld, and Ingalls, I9653 Meyer, Parkmaa, and 
Panos, 1966g Meyer and Parkman, I9673 Heyer, Parîcman, Panes, 
Stewart, Bobbins, and Bonis, I967). Although increases in 
titres of pre«e2?isting antibodies have been reported in persons 
e^ tposed to a subsequent infection of measles, or when given 
measles vaccine (Erugman, Giles, Eriedman, and Stone, I965; 
Bolgin, levine, l^arkham, Oabasso, Weichsel, Ruegsegger, and 
Cox, i960) these **booster” type antibody responses have not been 
noted in immune persons after rubella exposure. Ihis observation 
is confirmed in this study; only 14 two-^fold increases in 
titre occurred in IO6 immune Individuals who were in contact 
with virologically proved rubella (table 25). ïhis increase in 
titre was considered to bo within the lliBits of laboratory error.
It is unfortunate that one second attack did occur as 
othewiso one could give unequivocal assurance to tlie immune 
pregnant rubella contact. Bie risk, however, is at least less
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laa oae pei’
îîhe analysis of the clinical features of the index 
o@3'©B of rubella (table 20) supports’ the findings’ of Young 
and Ramsay (l96j) that a rash was an almost constant feature 
of the disease and that posterior cervical lymphadenopatliy 
was common* ïhe low incidence (3 per cent) of arthritis 
was probably due to the fact that nearly all the index cases 
were children and it has been previously noted that this 
complication is more common in adults (izky, Billant© and
Tho virus was isolated from over half the patients in 
the first three days after the onset of the rash (table 21). 
Ihese patients were more infectious at this time than later as 
the isolation rate dropped to between 25 and 30 cent during 
the next three days; thereafter the virus was rarely isolated, 
lliis confirms the esÊperimental work of Green and his colleagues 
(1965) and emphasizes the importance of taking swabs as near 
to the date of onset of the rash as possible in order to obtain 
a positive isolation.
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Conolnsions
That the rubella virus must infect a. large proportion 
of people both clinically .and subolinically at an early age 
is shoim by the fact that between 8.0 and 97 per cent of the 
individuals who took part in these studies already* possessed 
antibody to rubella* As only one second attack of rubella 
was noted it must be assumed that the majority of persons who 
possess antibody to rubella are protected from a further attack* 
Only the small proportion who do not possess antibody are at 
risk and therefore require protection*
By protecting the mother from rubella during the first 
four mon'khs of pregnancy it is hoped that foetal malformation 
is also prevented* G1 early passive immunisation with the 
present dose of immunoglobulin is of little value. Possibly 
a larger dose would be more satisfactory but this, in its 
turn, brings about such difficulties as the administration 
of large volumes of fluid and a greatly increased demand for 
a commodity that is already in short supply and is expensive.
During the past three years intensive research has 
taken place into the production of a live-attenuated vaccine
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against rubella. This had produced encouraging results 
and there is every likelihood that this vaccine will 
effectively eliminate the risk of infection to susceptible 
pregnant women. The administration of immunoglobulin with 
all its attendant difficulties will therefore become 
unnecessary. TTntil a vaccine comes into general use, however,
I
it is likely that immunoglobulin will continue to be given to 
susceptible women in contact with rubella during the first 
four months of pregnancy*
Recommendations
1. Every woman of childbearing age should have thhèr serum 
titrated for rubella antibody.
2. If susceptible, they should be advised that, if they become 
pregnant, they should avoid contact with patients suffering 
from rubella* This is especially important in the case
of schoolteachers, nurses in paediatric wards where they 
lûay come into contact with babies suffering from congenital 
rubella and those working in infectious diseases hospitals. 
3* Bhould a suceptible woman who is within the first four 
months of pregnancy anticipate that she is liable to come 
into unavoidable contact with rubella (e.g. during an 
epidemic) she should be given large doses of immunoglobulin 
(at least 41500 mg.) that have been taken from a batch of 
hi^i rubella antibody titre. If she is in contact with
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a patient suffering from rubella a sqrum sample should 
be obtained as soon after contact as possible and again 
five to six weeks later to determine whether she has become 
infected. If infection occurs therapeutic abortion may 
be offered.
4* Because of the shortage of inmunoglobulin, priority for 
large doses should be given to;
(a) contacts who are in very early pregnancy because 
of the greater risk of major foetal Biarlformation;
(b) pregnant household contacts because of the greater 
likelihood of infection than when the index case 
is outside the homo#
5# Alternatively, if a susceptible woman is in contact with 
rubella, immunoglobulin may be withheld in view of the 
serious doubts about its efficacy, and therapeutic 
abortion offered to those who become infected.
6. The haemagglutination*^inI’iibition test should replace the 
neutralisation test for the serological diagnosis of 
rubella since a result is obtained much more quickly.
7. As active immunisation with a live-attenuated rubella 
vaccine appears to be a more promising proposition in the 
prevention of rubella, than the administration of immuno­
globulin, every effort should be made to bring a satisfactory 
vaccine into general use as soon as possible#
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giAPTER 9
s m w m x
A series of epiclemiologioal studies has been carried out 
among women in several areas of the ÏÏnited Kingdom and 
among cadets of the Metropolitan Police Force with the 
object of investigating various aspects of the natural 
history and prevention of arubella.
1* The majority of persons investigated already possessed
antibody to rubella by the time they reached adult life.
The proportion immune varied in the different geographical 
areas studied and ranged from 96 per cent of the women from 
heeds and Keighley to 80 per cent of those from London. 
Talcing all the regions into consideration 91 per cent of 
the women examined were immune,
2* Immunity to rubella varied to some extent with age. Of
those less than 20 years, 04 per cent were immune compared 
with over 90 per cent in older women, ‘
3. Among the immigrant population living in the ÏÏnited
Kingdom, the African and West Indian populations appeared 
to have a smaller proportion of persons who possessed 
rubella antibody*.
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4*„ The reported history of an attack of rubella did not
agree with the patient Te iïïinmnity to rubella*
5* Women without children were more likely to be
susceptible to rubella than women with families,
6. A large proportion (97 cent) of the young adult
males investigated also possessed antibody to rubella.
7# Ampoules from fifteen batches of British immunoglobulin 
were tested for neutralising antibody to rubella. All 
contained antibody, the titres ranging from 1 s 60 to 
1 : 320.
Attack rate in rubella contacts given immunoidobulin
8, (a) V/hen no account was talcen of the immunity of pregnant
women in contact with cases diagnosed clinically as having 
rubella, only 1,4 por cent developed an illness with a rash 
after having had an inoculation of 750 mg. immimoglobulin.
(b) Mien virological studies were performed, however,
and the analysis restricted to susceptible pregnant women 
who were in home contact with a case of rubella proved by 
isolation of the virus, then 80 per cent became infected 
either clinically or subolinically despite having had 
750 mg. immunoglobulin.
9. Even when the dose of immunoglobulin m s  increased to
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3,000 mg., four of six susoeptiblo women developed the 
disease after oontaot with a oonfirmed case of rubella. “
10. The risk of oontraoting rubella was much less if the 
index case was not a member of the same household. The 
attack rate for inoculated, susceptible pregnant women 
in oontaot outside the home vzith a oonfimaed case of 
rubella \jas a quarter of the rate found for homo contacts.
Afej5aofej?aie_ia.mino^^
lié Fifty per cent of uninoculated susceptible women of
childbearing ago developed rubella after home contact with 
a. virologiouUy proved case* As 80 per cent of pregnant 
women beoame infected, preg^mioy may increase susceptibility. 
12 é In the Hendon Police Oollege a residential community -
100 pea? cent of those cadets who were susceptible developed 
rubella after the introduction of infeotio|> into the college.
Second attacks of rubella
13. Second attacks of rubella were found to be rare. Only
one of lèé immune pregnant mothers developed a second 
attack of rubella following exposure. The clinical diagnosis 
was verified by virus isolation but neither in this mimm 
nor the 105 others did a four-fold rise in antibody'titre 
occur.
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. Gufaolinioal attaoka
14. (a.) Tlie number of subolinieal attacks of rubolla in the 
oomimities studied was probably coneiderablo as judged 
by the proportion. (88 per cent) of women who possessed 
antibody to rubella but who did not give a past history 
of clinloai infection#
(b) Eleven per cent of uninoculated women and 14 per cent 
of uninoculated men who developed rubella had a subclinioal 
infection*
(c) Forty-eight per cent of the vzomen who developed rubella 
after immunoglobulin had a subclinioal Infection# Immuno­
globulins therefore, may suppress the clinical features of 
the disease but not prevent infection#
15. Rubella virus was isolated in about 50 per cent of
specimens obtained from cases of rubella during the first 
three days after the onset of the rash* During the next 
three days the virus was isolated from about 25 per cent 
of oases; thereafter it mbb seldom isolated.
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1# The work described in this thesis was carried out 
in the Epidemiological Research Laboratory of the Public 
Health Laboratory Service in collaboration with the staff 
of the Vinih^îReferenoe Laboratory, Central Public Health 
Laboratory a^ id the Directors of the Public Health and 
Associated Laboratories at Bedford, Bristol, Carmarthen,. 
County Hall (London), Coventry, Exeter, Ipswich, Leeds, 
Liverpool, Manchester, Newcastle, Northallerton, Nottingham, 
Oxford, Peterboroxi^a, Portsmouth, Salisbury, Sunderland, 
Swansea, Taunton and Winchester.
2* The work was conducted under the supervision of
Dr. TiM. Pollock, Director of the Epidemiological Research 
Laboratory, and Dr, A.D. Placrae, Director of the Virus 
Reference Laboratory* It is a pleasure to record my 
indebtedness to Dr; Pollock and Dr. Macrae for their 
generous advice, encouragement and help during the planning 
and conduct of the studies and. in the preparation of this 
thesis.
I also wish to thank the following peozsons for their 
assistance;-
The many general practitioners who recorded details 
and provided specimens from their patients.
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The staff of m a w  Public Health Laboratories who 
examined the specimens*
lies, Gwendoline Smith of the Epideiaiologioal 
Research Laboratory for her invaluable help with the 
records and for t;y>p)ing this thesis; Dr, D,L# Miller and 
BIT, W*B, Fletcher for guidance with the preparation of the 
thesis; & *  ¥. Clifford for assistance with the diagrams; 
Mrs, Judith Diamond and ¥w b * Radha fcrasimtian who gave 
advice on some of the statistical analyses,
Financial assistance was provided by the Ministry of 
Health*
3* The work was conducted and the thesis prepared while
serving as a member of the Epidemiological Research 
Laboratory*
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oqllfjgtiom A m  qf data
Once the clinical d©tai3.s and laboratory findings were recorded# 
the completed cards were returned to the Epidemiological Research 
Laboratory at the Central Public Health Laboratory# Oolindalo, London# 
from the various virus laboratories participating in the studies,
Each card was checked on receipt at Golindalo so that inaccurate or 
incomplete information could be detected* Such cards were returned 
to the appropriate doctor and his help requested®
For all the studies, apart from that conducted at the Metropolitan 
Police Training Opllego, in which tîae amount of informtion was small 
enough to be conveniently azmlysed by hand, the record cards were 
coded® Coding sheets were prepared to enable the data on the cards 
to be transferred into a numerical code* Once completed the code was 
checked by a person other tîian the one who performed the original 
coding* In this way errors were more likely to be detected than if 
the coder checked his own cards®
Punch cards were then prepared from the coded information* The 
punch cards were of tîie type manufactured by International Computers 
Ltd® and each contained 80 columns (i*e# the card was able to record 
up to 80 items of information)* As already described for the coding 
of the record cards, an independent person checked each punch card 
using a verifier®
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These various prooedures allowed the relevant information 
to be extracted by means of a counter-sorter*
ill
APPMDIX II 
OOLXÆiCTIOM AM) TRANSPORT OF SMIMBHB
a) Blood
In the Investigations described, venous blood samples of 
between 2 and 5 ml® were obtained® \%ere paired samples were 
required the first specimen was taken as soon after contact 
with the case of rubella as possible and the second five to 
six weeks later® This interval allowed for the incubation 
period and development of antibody in a susceptible person v/ho 
became infected® The specimens v/ere sent to the appropriate 
virus laboratory by the quickest available means; in most 
instances this was by letter post. In some oases transport 
by car was arranged® The specimens were kept in sterile ^ 
fluid 02, McCartney bottles which were wrapped in wadding and 
put in stout cardboard containers® The containers were placed 
in padded envelopes which were then sealed# Thus the 
possibility of leakage of blood was kept to a minimum (see 
appendix page acvi ),
b) MMfoat ana nasal swabs
The swabs were made of sterile cotton wool and kept in 
glass test tubes until required#
The majority of patients had their noses and throats 
swabbed at the time the rash was present® Successful
isolation of the rubella virus is more likely at this stage 
of the disease (Green, Balsamo, Giles, Krugmanfcnd Mirick 1965)
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Once taken, the swabs were dipped into bijou bottles containing 
virus transport media, the ends broken off and the caps of the 
bottles replaced securely*
The virus transport media was prepared under aseptic 
conditions at the Central Public Health Laboratory# Colindale, 
London, using the follov/ing formula;-
Hank's balanced salt solution 990.0 ml.
bovine albumin solution 10*0 ml. 
k*hfo sodium bicarbonate solution^g
Each bijou bottle contained 4 ml* of the above solution at a 
HI of 7*0 to 7 «2, Phenol red (0*002}f>) was used as em indicator 
so that a change in HI could be noticed and the bottle discarded, 
The bijou bottles were placed in containers similar to 
those used for the blood samples. The specimens normally 
reached the laboratory either by post or by hand within 2k hours 
of being taken. If there was the possibility of delay the 
doctor was asked to place the bijou bottles in a refrigerator at 
+4^0 until they could be sent to the laboratory ®
m m x  III
LABORATORY METHODS
Xn the laboratories taking part in the stuây# uriiform though not 
necessarily completely identical methods were used. A continuous 
cell line of rabbit kidney (RJi.13) cells (Beale, Christofinis and 
Furminger, 1963) was employed and the sensitivity of these cells was 
checked by repeated titration of known strains of rubella virus® A 
group of control sera was also circulated among the laboratories for 
titration so that a uniform standard could be ensured (table 26). 
a)
Serial two-fold or four-fold dilutions of serum in O.J ml® 
volumes were mixed with equal volumes of the 'West Point* strain of 
rubella virus adapted to grow in RJi® 13 cells and diluted to contain 
about 100 T.C.Î)® in 0«1 ml. After incubation at 36^0 for 75 minutes 
the viruB-serum mixture in 0*2 ml® volumes was inoculated into each 
of two E*K. 13 tubes® A positive human serum of knomi titre was 
included in each test. Tubes were read on the fourth end sixth or 
seventh days after inoculation® The degree of oytopathio effect 
was estimated by direct microscopy* The end-point in the antibody 
titration was taken as the highest dilution of serum causing complete 
or almost complete inhibition of the oytopathio effect. Titres were 
expressed as the initial serum dilution before mixing with virus*
Sera were absorbed ?d,th kaolin for one hour at room temperature
and after oontrifugation with 50?î chick red blood cells for at least
vx
two hours at they were then inaotivated at 56*^ 0 for 30 minutes
(Stewart, # Hoppe# Douglas, Hamilton and Moyer, 1967)*
Serial four-fold serwa dilutions in 0.025 ml. volumes were placed
in rniorohaemagglutinatioii plates and mixed with equal volumes of
antigen containing 4 to 8 hnemagglutiiïating units® After holding
at room temperature for one hour 0.025 ml. of a O.léjS suspension
of chick red blood cells was added to each cup. The plates were
refrigerated for tliree hours and the titres read. Antibody
titres were expressed as the highest dilution of serum producing
complete inhibition of hsemagglutination. Appropriate controls
were included in each batch of tests.
II Virus isolation
Virus isolation was based on the method of Hutchinson and
Thompson (1965). 0.4 ml. of throat swab extract were inoculated
on to a tube of E.IC.13 colls containing sodium bicarbonate, rabbit
serurft, antibiotics end Parkers **199“ solution. The tubes were
then rolled at 35^8 overnight and the medium changed to a
maintenance medium of Eagle's solution (Burroughs Wellcome). The
o
tubes were rolled at 35 8# examined and the medium changed twice 
weekly, those showing the oytopathio effect (G.P.B.) of rubella 
virus being subcultured. Those showing no oytopatMc effect 
after 14 days were subcultured and the subculture observed for a 
further fortnight. If after this passage no evidence of rubella
vil
oytopathy was found tîie specimen was eonsidered negative. 
Isolates were identified by neutralisation v/ith a rabit 
antiserum prepared with the “West Point** strain.
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APPEWDIX IV
Xn the ïïnlteâ ICingdoni limmioglobulin was made available 
in 1954 for pregnant women in contact with rubella during 
early pregnancy. It is distributed in Bngland and Wales by 
the Public Health Laboratory Sez'viee # and in Scotland by the 
National Blbod Transfusion Service* The British product is
5.
mmifactured by the Blood Products Laboratory, Lister 
Institute of Preventive MedJ.cine, Blstree, Hertfordshire# and 
by the Blood Products Unit, South East Regional Blood 
Transfusion Centre, Edinburgti® Occasionally the supply is 
supplemented by Dutch# French and Swiss material# The 
batches of immimoglobulln are usually prepared from citrated 
plasma by l^aotio&mtion with othei* usmig the method of KeWick 
and Mackay (19%) or by fractiomtion with ethanol, the method 
of Kistler and Hitsohmsnn (1962). The solution contains 15g* 
per cent protein and 1:10,000 thiomersal, a 750 mg# dose being 
contained in 5.1 ml#
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APPMDIX y
EXAI®I® 03? 3?BOT0C0IiS. BEOOHD OAKDS, 3P03SrCH CABDS 
CODHSTG SHEBÏS M D  STÆDA3ÏÏ) imCERS
Serological survey of adult females 
not recently in contact i?ith rubella®
P.HoL.S, FIELD TRIAL„
M  IW ESTIDATION INTO THE W^UEiiL IffiOTNITY TO 
RUBELLA IN VARIOUS SECTIONS OE^HE COmUNITfJ
P R O T O C O L
Estimation of the rubella  antibody t i t r e  has now become a 
standard procedure in  oerta,in laboratories and as i t  is  possible that 
a ru b e lla  vaccine may become available in  the next few years, i t  is  
important to obtain information on the natural immunity of the population 
to rube lla  to  enable these vaccines to be used in  the most economical 
and e ffe c tive  vf ay « A Public Health Laboratory Service Working Party  
has therefore been formed to  obtain th is  information.
OBJECT
To assess the t i t r e s  of rubella  antibody p a rtic u la r ly  in  females 
of various ages.
CENERAL PLM
Members of the P.H.L.S. Working Party w i l l  arrange to  obtain 
the serum samples in  th e ir  ovm area. A standard record card should 
be completed fo r  each p a tien t. The antibody t i t r e  w i l l  be estimated 
at the appropriate Public Health Laboratories and the results  analysed 
at the Epidemiological Research Laboratory at Colindale,
I/IETHOD
1. Members of the Working Party w i l l  arrange with lo ca l centres
( ante-natal c lin ics  would probably be the most l ik e ly )  to obtain about 
5 ml of blood from 100 female patients in  each f iv e  year age group 
between 20 and RO years of age together with 100 samples from patients  
of various ages under 20 years and the same number from patients over 
4j0 years of age.
2* The blood samples should be sent unfrozen to the laboratory but
should t i t r a t io n  of the sera be delayed, they should be stored at A^C, 
or i f  there is  to be a considerable lapse of time, below -20 C,
3« Serum dilu tions of 4? 1 6 and 64 v f i l l  be used in  t it r a t io n s .
T itres  should re fe r to the i n i t i a l  serum d ilu tio n s .
4# A standard record card (Form 13) w i l l  be completed fo r  each
patient and returned to the Epidemiological Research Laboratory fo r  
analysis,
dr/ gvs,
20.9.66.
XX
Protocolo
Rubella Antibody Card
xii
RUBELLA ANTIBODY STUDY
j H o s p ita l...........
' ( If  applicable)
] Patient’ s Name
Address
Date of Birth
Past History of Rubella. YES  
(ring) NO
NO T KNOWN
If YES, approximate date.
j Number of pregnancies.
I Number of m iscarriages or s tillb irths .
i
I s ignature ;.................................................
Doctor /  Nurse
Date.
FORM 13
For O ffice  
Use Only
2 3 4 5
6 7 8
Spare 
9 10
I I 12 13
14
□
15 16 17
IB
□
19
□
FOR LA B O R A TO R Y USE
Name of Laboratory,
i Date specimen taken
Antibody level
Signature,
Laboratory Director
D ate .
20 21
22 23 24
25
□
2 -
25, Antibody le v e l -
<4 = 1
4 = 2
8 = 3  
16 = 4
32 = 5
64 =: 6
)>■ 64 = 7
Box No,
RUBELLA MTIBODY SURVEY ( Card No. 13)
CODING-
Number allocated to investigation .
3 - 5 Number alloca,ted to the p a tien t.
6 — 8 Spare
9 N a tio n a lity  -  B r itis h  (including E ire ) 1 ,
I  ndi aiy'Paki s t  ani 2 .
West Indian 3.
European 4.
African 5.
Other 6 ,
Unlcnown 9.
10 Spare
1 1 - 1 2 Age ( i . e .  Number of years old at date of blood sample)
I f  age is less than 1 year, put 10 in  Box 11 and number of
months in  Box 12.
I f  age is  greater than 10 years, code number of years in  boxes
11 and 1 2 .
I f  less than 10 years but greater than 1 year, put 0 in  
Box 11 and number of years in  Box 12,
13 Spare
14 Past H istory of Rubella -  YES = 1 ,
NO = 2.
NOT NNOm= 9.
13 -  16 Number of years before specimen talcen.
I f  less than 1 year, put 10 in  Box 15 and number of months 
in  Box 1 6 .
I f  greater than 10 years, code number of years in  Boxes 15 
and 16,
I f  less than 10 years but greater than 1 year, put 0 in
Box 15 and number of years in  Box 1 6 .
I f  "NO" or Not knovm, code Boxes 15 and l 6 "0" "0",
17 Spare
18 Actual number of pregnancies,
19 Actual number of miscarriages or s t i l lb ir th s ,
20 “ 21 Spare,
22 Month of obtaining blood -  Jan, = 1 , Eeb, = 2, etc,
Nov. =11 Dec, = 0.
23 Last d ig it  of year number, i . e .  1966 = 6 ,
24 Spare
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Coâina Sheet
Iiîvestxf^ ation iîito the pi^ opliylaotio effect 
of 750 mgo limuaogloWllm when given to 
women in oontaet v/ith rubella during the 
first four months of pregmncy#
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ProtocoP'
M  IM^STIG-AJION INTO THE EFFICACY OF G-MM GLQBULIM 
IN  THE PREVENTION OE RUBELLA IN EREG-NANCY.
P R  0 T 0 0 0 L
INTRODUCTION
U n t il  a vaccine against ru b e lla  becomes availab le  gamma, 
globulin w i l l  probably remain the usual method of protection .of 
women in  contact w ith the disease during the e arly  months of 
pregnancy. Doubt s t i l l  ex is ts , hov/ever, about the e ffic ac y  of 
gamma globulin in  the prevention of in fec tio n  and the optimum dose 
has also s t i l l  to be determined.
A fu rth e r problem is  that many women already have n eu tra lis ing  
antibody to ru b e lla  virus in  th e ir  serum and i t  may not be necessary 
io  give them gamma globulin fo r  protection . I t  is  only recen tly  
that the measurement of the -erum ru b e lla  antibody t i t r e  has become 
a standard laboratory procedure and i t  is  now being carried  out in  
several lab o ra to ries . I t  should, therefore, be possible to see 
whether the woman is  already protected and i f  not, to determine i f  
the dose of gamma giobulia  given is  s u ffic ie n t to prevent in fe c tio n .
To study these problems a Worldng Party of the Public  
Health Laboratory Service, has been established and i t  is  hoped to 
gain the co-operation of those Laboratory Directors responsible 
fo r  issuing gamma globulin , together v/ith those General P ractitioners  
who are administering i t  to female ru b e lla  contacts in  the f i r s t  
three months of pregnancy.
OBJECTS
1 . To assess the amount of neu tra lis ing  antibodÿ to ru b e lla
virus in  v/omen requesting gamma globulin fo llow ing contact 
with ru b e lla  during the f i r s t  three months of pregnancy.
2_. To assess the e ffic ac y  of gamma globulin in  suppressing
the development of ru b e lla .
5 . To fo llow  up babies born of unprotected mothers to look
fo r  evidence of congenital ru b e lla .
GENERAL PLAN
Laboratory D irectors receiving a request fo r  gamma globulin  
to be issued to a pa tien t in  the f i r s t  three months of pregnancy 
who has been in  contact w ith ru b e lla  vsLll arrange v.ith the General 
P rac titio n er fo r  a blood sample to be taken fo r  ru b e lla  antibody 
estimation before the gamma globulin is  given
The dose of gamma globulin w i l l  be taken from a reserved 
batch of known ru b e lla  antibody t i t r e .
Five to six weeks la te r  the General P rac titio n er w i l l  be 
asked to see the pa tien t again and a second blood sample taken.
- 2
An attempt should also he made to confirm the diagnosis 
in  the o rig in a l case by taking throat and nasal swahs or i f  not 
feasib le  at the tim e, a blood sample retrospectively  which, i f  
negative, w i l l  show that in fectio n  probably never took place.
I f  possible, throat and nasal swabs should be talcen from 
babies born of mothers who developed rubella  despite gamma 
globulin, as soon a fte r  b ir th  as possible.
SUPPLIES
1.
Pregnant Contact Record Card ( l )  Wo, 25 (B Iuo)
To record c lin ic a l  and laboratory information  
Regarding the pregnant-rubella contact.
Pregnant Contact Record Card (2) Wo. 26 (Pink)
To record the protective e ffe c t of gamma globulin  
and the laboratory results  obtained from the second 
blood sample.
Index Case Record Card Wo, 27 (Gold)
To record c lin ic a l  and lab-oratory information  
regarding th% index case of ru b e lla .
In fa n t Record Card No. 29 (White)
To record the outcome of the pregnancy and the 
resu lt of throat and nasal svfabs talcen from the 
in fa n t,
2. CONTAINERS. (Ucinally MoCwnkoy ^ fl, • z .)
For co llec tio n  of the blood samples,
3, VmUS SWABS AND BIJOU BOTTLES.
For swabbing the throat and nose and transporting  
the swabs to  the laboratory,
4" GAMIA GLOBULIN,
This w i l l  be talcen from a reserved batch of kn^ w^n 
ru b e lla  antibody t i t r e  which w i l l  be issued to the 
Laboratory Directors from the. Epidemiological Research 
Laboratory, Colindale,
Î/EBTHOD
A, Directors of Public Health Laboratories should arrange with
General P ractitioners  requesting gamma globulin fo r th e ir  patients  
who have been in  contact with ru b e lla  during the f i r s t  three months 
of pregnancy to : -
1 , Take about 5 fo of blood from the patient and send 
th is  to  the appropriate laboratory, together w ith  
form Wo, 25 (Pregnant Contact Record Card ( l ) .
/%
_ 3 -
2. Give 750 mgm of gamma globulin intram uscularly.
This gamma globulin w i l l  be taken from the reserved 
batch.
Attempt to confirm the diagnosis by taking throat 
and nasal swabs from the index case, p r /a lte rn a tiv e ly , 
a sample of 5 ml of blood and return th is  w ith form Wo,
27 (index Case Record Card) to the laboratory,
4 . Arrange to see the contact in  f iv e  to s ix  weeks' time fo r
a second blood sample of 5 ml. Form Wo, 26 (Pregnant 
Contact Record Card ( 2) ) w i l l  be sent from the laboratory 
beforehand requesting th is ,
3 . Record the outcome of the pregnancy and arrange, i f
possible, to  take throat and nasal swabs from the in fant 
at b ir th  or as soon a fte r  b ir th  as possible, should the 
mother not have had antibody when gamma globulin was 
given. Form No, 29 (in fa n t Record Card) w i l l  be sent to  
the doctor near the estimated date of b ir th .
C ards.
Form No. 25 (Pregnant Contact Record Card ( 1) ) w i l l  be 
stamped with an id en tify in g  number. This number should be copied on 
to each subsequent card issued in  respect of the contact, index 
case or in fa n t, i . e .  Forms No. 26, 27 and 29.
The results  w i l l  be analysed at the Epidemiological Research 
Laboratory, Central Public Health Laboratory, Colindale Avenue, 
London, N.W.9*
dr/ gvs,
7th November, 1966,
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EFFICACY OF GAMMA GLOBULIN IN THE PREVENTION OF •
RUBELLA IN PREGNANCY_______ _
U n til a yaocine against rubella  becomes ava ilab le , gamma globulin  
w i l l  probably remain the usual method of protection of women in  contact 
with the disease during the early  months of pregnancy.
Doubt s t i l l  ex is ts , however, about the e fficacy  of gamma globulin  
in  the prevention of in fec tio n  and the optimum dose has also s t i l l  to  be 
determined. Is o la tio n  of the ru b e lla  virus and measurement of the serum 
ru b e lla  antibody t i t r e  have now become standard procedures in  several 
laboratories and i t  should, therefore , be possible to determine whether 
the woman already has antibody and i f  not, to determine i f  the amount 
of gamma globulin is  s u ffic ien t to  prevent in fec tio n .
Before giving the gamma globulin , about 5 ml of blood should be 
taken from the contact to  determine the serum antibody t i t r e .  The b o ttle  
which is  found in  the carton surrounded by the blue form should be used to  
store the blood. I t  should be c le a rly  lab e lled , replaced in  the carton 
and surrounded by packing. The blue form (No. 25) should then be completed 
and wrapped around the carton. Please do not fo ld  i t  as th is  w i l l  make 
the subsequent sorting of forms d i f f ic u l t .  The gamma globulin  is  also 
enclosed and should be given intram uscularly.
In  order to confirm that the illn ess  with which the patien t v/as 
in  contact was in  fa c t ru b e lla , throat and nasal swabs should i f  possible 
be talcen from the o rig in a l case. This w i l l  usually only be feasib le  i f  
the o rig in a l case and the contact attend the same doctor.
Once taken, each swab should be placed in  one of the b ijo u  bottles  
found in  the carton which is  surrounded by the gold form, the end broken 
o ff and the cap firm ly  replaced. Each b o ttle  should be lab elled  v/ith the 
name of the o r ig in a l case and c le a rly  marked "throat" or "nose". The 
glass swab containers need not be returned. I f  the rash has disappeared, 
an attempt should be made i f  possible to  co llect about 5 ml of blood from 
the o rig in a l case in  the b o ttle  which is  found in  the same carton.
The specimens should be firm ly  packed in  th is  carton, the gold 
coloured form (No. 27) completed and wrapped around the carton. The 
cartons and forms should be returned in  the o rig in a l envelope, A prepaid, 
addressed lab e l is  enclosed*
The resu lt of the contact’ s antibody t i t r e  w i l l  be sent to the  
doctor as soon as possible.
I f  the resu lt indicates that the pregnant contact does not possess 
ru b e lla  antibody ( i . e .  she is  susceptible to the disease) a second dose of 
globulin w i l l  be sent to the doctor provided she is  not outside the 
incubation period of the disease. In  addition, a form and container w i l l  
also be dispatched about 5 weeks a fte r  the date of contact fo r co llec tion  
of the second blood sample. T itra tio n  of th is  sample w i l l  ascertain  
whether the contact has developed rubella  (e ith e r c lin ic a l ly  or sub­
c lin ic  a lly ) o
I t  is  hoped to fo llow  up the in fan t i f  the mother becomes in fected .
Your help v/ith th is  investigation  is  g reatly  appreciated.
XViii
instruotionB praotitiomer v;ith the pack
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c«ntaet E«oord Card (l)
a) Front
I
PUBLIC HEALTH LABORATORY SERVICE 
RUBELLA INVESTIGATION 
PREGNANT CONTACT RECORD CARD (I)
Surname of C ontact..
Other names .
Address  ....... .
Date of birth  X....../..
Date of L.M.P.  /....... /..
Date o f contact with rubella  / , ..... / .
Date o f onset of rash In original case  / . ..... / .
Name of original case ( If available).....................................
Does original case stay In the same household? YES /N O
Date specimen collected.......................................  / ..... / .
Date gamma globulin given  /....... / .
Dose of gamma globulin ..........................  mgm.
Batch Number  .................
Name of doctor 
Address............
FOR LABORATORY USE
Laboratory Number « ...........«........ «............ .......... .........
F irs t serum antibody titre  (In itia l d ilu tion) please ring 
<  4. 4, 8 .1 6 , 32, 64. > 6 4
Laboratory........................................................................ .
FORM 25 
For Office Use
b) Eeverae
RUBELLA INVESTIGATION 
PREGNANT CONTACT RECORD CARD (I)
Instructions
1. Please give details on this form of each patient who Is In contact 
w ith rubella during the firs t three months of pregnancy.I our
2. A blood sample of about 5 ml. should be sent with the form.
3. An attempt should be made to confirm the diagnosis of rubella In 
the original case by taking throat and nasal swabs, or alternatively 
5 ml. o f blood If  the patient has recovered from the disease. A ll 
specimens from the original case should be accompanied by form 27.
4. Forms and specimens should be sent to :
xzi
PUBLIC HEALTH LABORATORY SERVICE 
RUBELLA INVESTIGATION 
PREGNANT CONTACT RECORD CARD (2)
Contact** No.  .................... .
Surname o f C on tac t  .........
Other names............................ .
Address  ...................................
Did contact develop rubella? YES/N O
If YES, please give date of onset o f rash.
Is pregnancy progressing ? YES /N O
If NO, please give reason
Date second specimen collected ./ /.
Name of doctor 
Address  ....
FOR LABORATORY USE
Laboratory number  .............................. ...........................
Second serum antibody titre  ( in it ia l d ilu tion) please ring 
<  4. 4, 8, 16. 32. 64. >  64.
FORM 26 
For Ofrico Ue#
□
□
zxli
b) Rerera»
RUBELLA INVESTIGATION 
PREGNANT CONTACT RECORD CARD (2)
Instructions
1. This form should accompany the second blood sample o f 5 ml. 
taken from a patient who had been given gamma globulin for 
protection against rubella 5 to 6 weeks previously.
2. The form and specimen should be sent to :
xxUl
Indaab Case iieoord Card
X t
a) ) Î£SSBSl
I
PUBLIC HEALTH LABORATORY SERVICE 
RUBELLA INVESTIGATION 
INDEX CASE RECORD CARD
Surname of Index Case
Other names .
Address.........................
Date o f birth
C lin ica l features (please ring).
Rash
Lymphadenopathy
Fever
A rth ritis
Other (please state)
Date of onset o f rash
Date of throat and nasal swabs
Date o f blood sample ( I f  applicable)
/  /.
Name o f doctor .... 
^^ ddresg............
FOR LABORATORY USE 
Isolation from throat swab
YES
NO
NOT ATTEMPTED
Isolation from nasal swab
Serum antibody level ( I f  applicable)
YES
NO
NOT ATTEMPTED
FORM 27 1  
For O ffice Use
□
□
I
I
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b) Rerer««
RUBELLA INVESTIGATION
INDEX CASE RECORD CARD 
Instructions
1. Please give details on th is  form of the Index case o f rubella who 
was In contact with the pregnant patient.
2. Throat and nasal swabs In separate bijou bottles should be talcen 
as soon as possible, or a lternatively a blood sample of 5 ml. I f  the 
patient has recovered from the disease.
3. The form and specimen should be sent to :
Postage 
will be 
paid by 
Licensee
N o  Pos tage  
'^ tamn 
nccessa* y i f  
p o s te d  in 
G r e a t  B r i t a i n  
o r  N o r t h e r n  
I re la nd
BUSINESS REPLY SERVICE 
Licence No. N W  1473
E p i d e m i o l o g i c a l  R e s e a r c h  
C E N T R A L
5M D A L E  AVENUE,
(RUBELLA INVESTIGATION)
a
Box îîo.
— 2 —
Dose of Gamma G lobulin*
< 750 mgm = 1
750 " = 2
> 750 - <1500 = 3
1500 " 4
>1500 -  <2250 = 5
2250 = 6
>2250 -  <3000 = 7
3000 and over = 8
NOT KNOWN = 9
NOT STATED = 0
19 Batch Number of Gamma G lobulin ,
LKG, 121 1
123 2
127 3
131 4
138 = 5
141 = 6
143 = 7
Other reserved
batches = 8
Other batches = 9
NOT m o m  or
NOT STATED -  D
20 F ir s t  serum antibody t i t r e ,
< 4  1
4 2
8 = 3
16 = 4
32 5
64 = 6
>64 = 7
Not tes ted  = 8
Not stated  -  9
Nolo te s t = 0
21 -
H ,Io  tes to  
^8 = 1
8 2
16 = 3
32 4
64 = 5
128 6
>128 = 7
92 " Snare
RUBELLA INVESTIGATION -  GAMMA GLOBULIN. ( Card No. 25 -  Blue)
CODING
Box No.
1 " 2 Number a llo ca ted  to  member of Working P arty ,
3 - 6  Number a llocated  to  ru b e lla  contact,
7 - 8  Age ( i . e .  Number of years old at date of blood sample).
I f  NOT KNOm -  code 9 . 9.
I f  NOT STATED- code 8 . 8 ,
9 - 1 0  Number of weeks pregnant at date of contact w ith  ru b e lla .
I f  g reater than 10 weeks, code number of weeks in  
boxes 9 and 10.
I f  less than 10 weeks, put 0 in  box 9 and number
of weeks in  box 10.
I f  NOT KNOWN -  code 9$ 9.
I f  NOT STATED- code 8 ,- 8 .
I f  before pregnanqy code 7 * 7 «
Number of days between onset of rash and date of contact.
I f  g reater than 10 days, code number of days in  boxes 11 
and 1 2,
I f  less than 10 days, code 0 in  box 11 and number of
days in  box 12, I f  contact i f  before date o f
I f  NOT KNOWN -  code 9. 9. rash Code 7 i i i  3ox 11 and number o f days between contact 
I f  NOT STATED- code 8 , 8 . and date o f rash in  box 12»
I f  te is  in te rv a l is  9 days or
13 Original__oajip of ru b e lla . greauer, code 9 in  box 1^.,
Household contact -  YES = 1
NO = 2
NOT KNOWN t= 9 
NOT STATED = 8
1 4 - 1 5  Number of days specimen co llec ted  a fte r  contact w ith  ru b e lla .
I f  greater than 10 days, code number of days in  boxes 
14 and 1 5.
I f  less than 10 days, put 0 in  box 14 and number of 
days in  box 1 5 =
I f  NOT KNOWN -  code 9. 9.
I f  NOT STATED- code 8 . 8 .
1 6 - 1 7  Date gamma g lo b u lin  given.
Number o f days a f te r  contact w ith  ru b e lla .
I f  greater than 10 days, code number of days in  boxes 
1 6 and 1 7 ,
I f  less than 10 days, code 0 in  box 16 and number of 
days in  box l7o
I f  NOT KNOWN,- code 9 . 9.
I f  NOT STATED- code 8 , 8 .
Box No,
RUBELLA INVESTIGATION - GAIVMA GLOBULIN. (Card No. 26 - Pink)
CODING
Development of ru b e lla  in  the contact,
YES = 1
NO = 2
NOT KNOWN = 9
NOT STATED = 8
24 -  25 I f  rash developed in  contact, code number o f days a fte r
adm in is tra tion  of gamma g lo b u lin .
I f  less than 10 days, put 0 in  box 24 and number of 
days in  box 25,
I f  10 days or g re a te r, code number o f days in  boxes 
24 and 25,
I f  NOT KNOWN -  code 9. 9 .
I f  NOT STATED -  code 8 , 8 ,
26 Continuation of pregnancy,
YES = 1
NO 2
NOT KNOW = 9
NOT STATED = 8
27 Reasons fo r  pregnancy NOT progressing.
NEVER PREGNANT = 1
MISCARRIAGE = 2
THERAPEUTIC ABORTION  ^ 3
OTHER REASON = 4
NOT KNOWN = 9
NOT STATED = 8
28 Spare
29-50 Number of weeks a fte r  f i r s t  specimen.
I f  10 weeks or g rea te r, code number of weeks 
in  boxes 29 and 5O.
I f  less than 10 weeks, put 0 in  box 29 and number 
o f weeks in  box 30,
31 Rise in  t i t r e ,
NO CHANGE -  0
1 Tube d iffe ren ce  = 1
2 Tubes " = 2
5 " = 3
4 " = 4
Cont’ d . , ,
- 4 -
Box No,
31 Cont^d,, Rise in  t i t r e .
5 tubes d iffe ren ce  = 5
6 " " = 6
7 " " = 7
NO BLOOD SUBMITTED = 8
OTHER REASON = 9
DR/GVS, 6 ,7.67#
RUBELLA INVESTIGATION -  GA#A GLOBULIN, (Card^No.
CODING
Box No,
32 -  33 Age ( i . e .  Number of years old at date of i l ln e s s ) .
I f  age is  less than 1 year, code 10 in  box 32
and number of months in  box 33»
I f  age is  10 years or g rea te r, code number of years 
in  boxes 32 and 33»
I f  age is  less than 10 years but greater than 1 year, 
code 0 in  box 32 and number of years in  box 33»
34 Rash.
I f  present -  1
I f  absent = 2
35 Lymphadenopathy
I f  present = 1
I f  absent = 2
36 Fever,
I f  present = 1
I f  absent = 2
37 A r th r it is
I f  present = 1
I f  absent = 2
38 Other
I f  present = 1
I f  absent = 2
39 Spare
40 -  41 Throat and nasal swabs. I f  swabs talcen but date
unknown, code 8,80 in  boxes 
Number of days a fte r  rash (o r other featu re  of i l ln e s s ) .  40 , 41®
 ^  ^ . , I f  not takenI f  10 days or g reater, code number of days an boxes 9  ^ 9^
40 and 41 «
I f  less than 10 days, code 0 in  box 40 and number 
of days in  box 41 «
42 -  43 Blood sample. I f  taken but date unknown
code 80 80 in  boxes 4-2 ® 43 ^
Number of days a fte r  the rash (o r other fe a t tre  of I f  not taken 
i l ln e  s s) ,  code 9 , 9 *
I f  g reater than 10 days, code number of days in  
boxes 42 and 43 «
I f  less than 10 days, code 0 in  box 42 and number 
of days in  box 43.
Box No,
44 Throat swab is o la tio n .
YES = 1
NO 2
NOT ATTEMPTED = 3
NOT STATED = 8
45 Nasal svfab is o la t io n ,
YES = 1
NO = 2
NOT ATTEMPTED = 3
NOT STATED = 8
46 Serum antibody le v e l,
< 4  1
4 = 2
8 = 3
-16 4
32 = 5
64 = 6
>64 7
NOT STATED = 8
BLOOD NOT
SUBMITTED = 9
DR/GVS, 6.7.67»
Studÿ- of the attack rat© of rubella
in female contact© of ohild'^ 'beaxdng 
age who were not given immunoglobulin,
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AN INVESTIGATION INTO VARIOUS EPIDEMIOLOGICAL 
ASPECTS OE RUBELLA
P R O T O C O L
INTRODUCTION
Although gamma globulin has been employed extensively in  th is  and 
other countries fo r the protection of women exposed to ru b e lla  during 
the f i r s t  trim ester of pregnancy, i t s  value has never been assessed 
adequately.
During the past year the Public Health Laboratory Service has been 
collaborating v/ith many general p ractitio n ers  in  investigating  the 
protective  e ffec t of gamma globulin . The general plan has been to  
study the incidence of ru b e lla  in  susceptible pregnant women in  contact 
at home who have been trea ted  w ith gamma globulin . I t  is  essential a t 
th is  stage to  obtain precise inform ation about the incidence of ru b e lla  
in  a control group of women exposed in  the home who are not given 
gamma globulin .
GENERAL PLAN
The investiga tion  w i l l  include any woman of child-bearing age who 
is  not pregnant and is  in  contact in  the home w ith a patien t w ith  
ru b e lla . To establish the diagnosis a throat and nasal swab should be 
obtained from the patien t and sent to  the appropriate Public Health  
Laboratory accompanied by a record card containing c lin ic a l  d e ta ils .
At the same time each woman of child-bearing age in  the home should have 
a serum sample withdrawn to determine s u s c e p tib ility . This serum 
sample should also be sent to  the laboratory w ith the appropriate  
record card.
I f  the sample is  shown to lack antibody a second specimen y / i l l  be 
requested s ix  weeks la te r  to  determine whether the contact has become 
in fec ted .
SUPPLIES
The following items w i l l  be issued by the Public Health Laboratory 
S erv ice:-
1 . RECORD CARDS
Index Case Record Card No, 56.
To record d e ta ils  of a case of ru b e lla .
Contact Record Card ( I )  No, 57,
To record d e ta ils  of a female household contact of between 
15 and 45 years of age.
Contact Record Card (2 ) No. 58.
This card w i l l  be sent only i f  the contact is  shown to  be susceptible 
( i . e .  lacks antibody in  the f i r s t  specimen),
2. CONTAINERS FOR BLOOD (usually  i  f l ,  oz. McCartney b o tt le s ) .
For co llec tio n  of blood samples,
/2.
3# VIRUS SWABS AND BIJOU BOTTLES CONTAINING TRANSPORT MEDIUM.
For swabbing the th ro a t and nose and fo r  transport of the 
swabs,
SPECIMENS
1 . Throat and Nasal Swabs,
These should be taken from the nose and throat as soon as 
possible from any case of ru b e lla  which occurs in  a household* 
The swabs should then be dipped in to  separate b ijo u  b o ttles  
containing virus transport medium, the ends broken o f f  and the 
caps replaced. The la b e l should be marked throat or nose,
2 , Blood,
Up to  5 ml o f blood should be taken, placed in  a McCartney 
b o ttle  and sent unrefrigerated .
METHOD
1 , A record w i l l  be made by the doctor on the Index Case 
Record Card of any case of ru b e lla  which occurs in  a household 
in  his p rac tice ,
2, Throat and nasal awaba should be taken from the case as soon 
as possible.
The specimens should be sent by le t te r  post together with  
the record card (No* 56) to the appropriate laborato ry.
Should there be any delay, the swabs should be kept 
re frig e ra te d  at around +4°C u n t i l  posted,
3* A l l  female home contacts of between 15 and 45 years o f age
should • be b led , the specimen to  be taken as soon a fte r  
contact as possible. This specimen should be sent to  the 
laboratory accompanied by Contact Record Card ( l ) .
4* This sample w i l l  be t i t r a te d  fo r rube lla  antibody at the
laboratory and i f  found to  be negative the doctor w i l l  be sent 
a request fo r  the second blood sample - s ix  weeks la te r ,  
accompanied by Contact Record Card ( 2) ,
5# Numbering of Cards.
A number w i l l  be stamped oh to  the Contact Record Card ( l ) ,  
To f a c i l i t a te  analysis and id e n tif ic a tio n  of the case and 
contact, i t  would be appreciated i f  th is  number is  copied on to  
a l l  other cards perta in ing  to  the contact.
DR/GVS.
20,11.67,
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Contact Record Cord (l)
a)
PUBLIC HEALTH LABORATORY SERVICE 
RUBELLA INVESTIGATION 
CONTACT RECORD CARD (I)
Surname of C ontact..
Other names..............
Address.....................
Date of birth  /....... /..
Date o f contact with rubella  / . ..... / .
Date o f onset o f rash In orig inal case  / . ..... /.
Name of original case ( If  available)  ..........................
Does original case stay In the same household? YES /N O  
Date specimen collected....................................  / ..... / .........
Name of doctor 
A ddress............
FOR LABORATORY USE
Laboratory Number................... ......... .................................
F irs t serum antibody titre  (In itia l d ilu tion) please ring 
<  4, 4. 8, 16, 32. 64, >  64
Laborato ry.......................................................................... .
FORM 57 
For Office Use
XXX
b) &ererM
RUBELLA INVESTIGATION
CONTACT RECORD CARD (I)
Instructions
1. Please give details on this form of each female patient (between 
the ages of 15 and 45 years) who is in contact with rubella.
2. A blood sample of about 5 ml should be sent with the form.
3. An attempt should be made to confirm the diagnosis of rubella in 
the original case by taking throat and nasal swabs. All specimens 
from the original case should be accompanied by Form 56.
4. Forms and specimens should be sent to :
xxxi
Contact Record Card (2l 
a) front
PUBLIC HEALTH LABORATORY SERVICE 
RUBELLA INVESTIGATION 
CONTACT RECORD CARD (2)
Contact’ s No..........................................  ».............. ....................
Surname of C on tac t.......................... ................ ..............................
Other nam es...................................   «................»..................
Address.............................      ».
Did contact develop rubella? Y E S /N O
If  YES, please give date o f onset o f rash.............../  /   
Date second specimen collected ........ / .» . . . / ........
FORM 58 
For Office Ua#
□
Name of doctor 
A ddress  ....
FOR LABORATORY USE
Laboratory num ber  ...................................   »............
Second serum antibody titre  ( In itia l d ilu tion) please ring 
<  4, 4. 8, 16, 32, 64, >  64. □
xxxli
b) Rc t w »*
RUBELLA INVESTIGATION
CONTACT RECORD CARD (2)
Instructions
1. This form should accompany the second blood sample of 5 ml 
taken from a patient who had been in contact w ith rubella.
2. The form and specimen should be sent to:
xxxlll
Index Case Record Cayd
a)
PUBLIC HEALTH LABORATORY SERVICE 
RUBELLA INVESTIGATION 
INDEX CASE RECORD CARD
Surname of Index Case
Other names  ..........
Address  ..............
Date of birth
C lin ica l features (please ring). 
Rash
Lymphadenopathy
Fever
A rth ritis
Other (please state)
Date of onset o f rash
Date of throat and nasal swabs
/ /.
/...-.A  
/ A
Name of doctor 
Address ............
FOR LABORATORY USE
Isolation from throat swab
Isolation from nasal swab
YES
NO
NOT ATTEMPTED
YES
NO
NOT ATTEMPTED
FORM 56
For Office Use
XXXiY
b) Revers*
RUBELLA INVESTIGATION 
INDEX CASE RECORD CARD 
Instructions
1. Please give details on this fomi of the index case of rubella who 
may have infected the female contact. .
2. Throat and nasal swabs in separate bijou bottles should be taken 
as soon as possible, or alternatively a blood sample of 5 ml if  the 
patient has recovered from the disease.
3. To fac i l i ta te  subsequent analysis the number given on form 57 
should be copied on to the top right hand corner of this card.
4. The form and specimens should be sent to;
3CH3C7
GMigg 'Sheet
CODIN&
Box No.
1 - 2  Number a llocated  to  member of Working Party,
3 - 6  Number a llocated  to  ru b e lla  contact,
7 - 8  Age ( i . e .  Number of years old a t date of blood sample).
If NOT KNO'.N - code 9. 9.
I f  NOT STATI.D -  code 8. 8.
9 - 1 0  O rig ina l case of ru b e lla
Number of days betv/een onset of rash and date of contact.
I f  greater than 10 days, code number of days in  boxes 9 and 10,
If less than 10 days, code 0 in box 9 and number of days in box 10,
I f  NOT i(NOûN -  code 9. 9.
I f  NOT STATED -  code 8, 8,
I f  contact is  before date of rash: code 7 in  box 9 and number of
days between contact and date of rash in  box 10, I f  th is  in te rv a l  
is  9 days or g re a te r , code 9 in  box 10,
11 Original case of rubella
Household contact -  YES = 1
NO = 2 
NOT mo\m = 9 
NOT STATED = 8
1 2 - 1 3  Number of days specimen collected  a fte r  contact w ith  ru b e lla .
If greater than 10 days, code number of days in boxes 12 and 13.
I f  less than 10 days, put 0 in  box 12 and number of days in
box 13#
I f  NOT KNOWN - code 9. 9.
I f  NOT STATED -  code 8. 8,
14 F irs t  serum antibody t i t r e ,  (N eu tra lisa tio n  Test )
< 4 = 1
4 = 2
8 = 3
l6 = 4
32 5
64 = 6
>64 = 7
Not tested = 8
Not stated = 9
H .I .  Test = 0 C o n t'd ...
15 H .I .  Test
<8 = 1
8 2
16 5
32 4
64 = 5
128 6
>128 7
16 Spare.
Box No. 
17
18 -  19
20 -  21
22
RUBELM INVESTIGATION -  CONTROL GROUP (Card No. 58 Blue)
CODro
Development o f ru b e lla  in  the contact.
YES = 1
NO 2
NOT KNOWN = 9
NOT STATED = 8
I f  rash developed in  contact, code number of days a f te r  contact
w ith index case.
I f  less than 10 days, put 0 in  box 18 and number of days in  box 19»
I f  10 days or g rea ter, code number of days in  boxes 18 and 19*
I f  NOT m o m  -  code 9. 9.
I f  NOT STATED -  code 8. 8.
Number of weeks a fte r  f i r s t  specimen
I f  10 weeks or greater code number of weeks in  boxes 20 and 21
I f  less than 10 weeks, put 0 in  box 20 and number of weeks 
in  box 21,
Rise in  t i t r e .
NO CHANGE = . 0
1 Tube d ifference = 1
2 Tubes " = 2
3 " " 3
4 I I 4
3 I I = 5
6 It I 6
7 " " 7
NO BLOOD SUBMITTED = 8
OTHER REASON = 9
x o - j i - J . j . U jL'i “  u u i N i j L i L u j j  v x a o u l - ' ,  i  u a x - u .  i v u ,  u o x - x a t :  j
CODING .
23 -  24 Age ( i . e .  Number of years old. a t date of i l ln e s s ) .
I f  age is  less than 1 year code 10 in  box 23 and number of 
months in  box 24
I f  age is  10 years or greater code number of years in  boxes 
23 and 24
I f  age is  less than 10 years but greater than 1 year, code 0 in  
box 23 and. number of years in  box 24.
25 Rash
I f  present = 1
I f  absent = 2
I f  NOT STATED = 8
26 Lymphadenopathy
I f  present = 1
I f  absent = 2
I f  NOT STATED = 8
27 Fever
I f  present = 1
I f  absent = 2
I f  NOT STATÏ D = 8
28 A r th r it is
I f  present = 1
I f  absent = 2
I f  NOT STATED = 8
29 Other
I f  present = 1
I f  absent = 2
I f  NOT STATED = 8
30 Spare
31 “ 32 Tliroat and nasal sv/abs
Number of days a fte r  rash (o r other feature  of i l ln e s s ) .
I f  10 days or g re a te r, code number of days in  boxes 31 and 32.
I f  less than 10 days, code 0 in  box 31 and number of days in  
box 32.
I f  swabs taken, but date unlmown, code 8, 8. in  boxes 31 " 32.
I f  not taken code 9* 9*
Cont* d . . ,
Box No,
rx—*—iKueatsetESssa
33 ” 34 Blood sample.
Number of - days a fte r  the rash (o r other featu re  of i l ln e s s ) .
I f  greater than 10 days, code number of days in  boxes 3.3 and 34.
I f  less than 10 days, code 0 in  box 33 and number of days in  
box 34.
I f  taken but date unknown code 8, 8, in  boxes 33 -  34.
I f  not taken code 9. 9.
35 Throat swab is o la tio n
YES = 1
NO 2
NOT ATTEMPTliD = 3
NOT STATED = 8
36 Nasal swab is o la tio n ,
YES = 1
NO 2
NOT ATTEHflPTED = 3
NOT STATED = 8
37 Serum antibody le v e l, (N eu tra lisa tio n  Test)
< 4  1
4 = 2
8 3
15 4
32 = 5
64 = 5
>64 = 7
NOT STATED = 8
BLOOD
NOT SUBMITTED = 9
H, I .  Test = 0
38 H . I .  Test
< 8  = 1
8 2
16 3
32 4
54 5
128 6
>128 7
Punoh Card
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(Public Health Laboratory Service)
Telephone: 01 -205 7041 
Telegrams: D e fe n d e r , L o n d o n , N.W.9.
COLINDALE AVENUE,
LQNDON, N.i
Dear Dr.
Assessment of G-amma Globulin in the Prevention of Rubella 
in Pregnanoy.
I enclose a report on your patient's antibody titre to rubella. Th 
information will be of great help in assessing the value of gamma globuli 
Thank you for sending it to us.
We are continuing to examine specimens from women given gamma globu 
and will be very glad if you will continue to send these samples. Meanwh
in order to make an adequate assessment of this substance, it is essentia
have information on the incidence of rubella in an adequate control group 
can best be obtained by a parallel study tn women of child-bearing age, i 
contact Tfith a case of rubella in the home, but who are not pregnant and 
therefore not given gamma globulin.
We should be most grateful if you could help with this phase of the 
investigation if the opportunity arises, by sending the following to us ;
1 • Throat and nasal swabs from a suspected case of rubella.
2. A blood sample (2-5 ml) from any non-pregnant woman of child­
bearing age Tfho is in contact with the case at home.
As with the present sample we will send you the antibody titr 
which you may like to know for any subsequent pregnancy. If
woman is shown to possess antibody to rubella (usually over 8
of women have rubella antibody)., no further specimens will be 
required, but if no antibody is found, we should like to send 
a second specimen to be taken about six weeks after the first 
see if she has become infected,
I enclose more detailed information together with record cards and 
containers for the samples. Further packs can be sent as required.
Any help you can give vd.ll be greatly appreciated. Please let me k
if I can provide any further information.
Yours sincerely,
Ends: D. Reid.
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1, Defects reported in infémts whose mothers had 
rubella during the first sixteen weeks of pregnancy.
2. Rubella neutrallsliM^ antibody titras found in women 
living in different areas of the survey.
3* Rubella neutralising antibody titres at different
ages.
4* Rubella neutralising antibody titres according to
place of origin.
5* Rubella neutralising antibody titres according to
the past history of rubella.
6. Rubella neutralising antibody titres according to
the number of pregnancies per patient.
7* Rubella neutralising antibody titres according tO
the number of misoaxriages and stillbirths per patients
8. Rubella neutralising antibody titres in 15 batches of
human immunoglobulin #
g. Attack rate of nibella among’ pregnant vromen given
750 mg. immunoglobulin after contact with a case of 
clinical rubella.
10 o Rubella among pregnant women given 750 immuno­
globulin after contact with a case of clinical 
rubella either inside or outside the home.
11# Attack rate of rubella pregnant women given
750 % #  iimmmoglobulin after contact with an index 
case from whom rubella virus was isolated#
12# Rubella among pregnant women who did not possess
antibody to rubella and who were given 750 mg. 
immunoglobulin after contact with an index case from 
whom rubella virus was isolated#
13# Interval between date of onset of rash in index case
and. development of rash in 12 home contacts given 
750 mg. immunoglobulin - rubella virus isolated from 
index case*
14* Age distribution of the pregnant rubella contacts
according to the possession of -antibody to rubella.
15# Attack rate of rubella among susceptible pregnant
household contacts given a second dose of iimmmoglobulin 
(1,500 Big.) after contact with an index case.
16* Attack rate of rubella among fema].e household
contacts of clinical rubella who were not pregnant and 
who did not receive immunoglobulin.
17* Attack rate of rubella tmong female household contacts
of rubella v/ho were not pregnant and did not receive 
immunoglobulin - rubella virus isolated from index case#
Table
18# Interval between the date of onset of the rash in 
index case and the development of rash in 15 home 
contacts who were not given imiiamioglobulin - rubella 
virus isolated from index case#
19# Ago distribution of the non**px’egnant rubella
contacts according to the possession of antibody 
to rubella#
20# Clinical features of the index oases diagnosed
clinically as rubella*
21# Interval (days) between the date of onset of rash
in the index case of rubella and the date of taking 
the swab, according to the isolation of the rubella 
virus#
22# Rubella haemagglutination-ihhibiting antibody
titres in 224 Metropolitan folioe Cadets according 
to area of origin#
25# Rubella haemaggXutinatlon*^iniiibiting antibody titres
in 224 Metropolitan Police Cadets and the development 
of rubella*
24* Rubella haemagglutination-inliibiting antibody
titres and elates of onset of rash in seven 
Metropolitan Police Cadets who did not possess 
mxtibody when in contact with oases of rubella#
Table
25, Frequency of rising neutralising, or haemagglutin-
atlon4,inhibiti% antibody titres in women with 
pre-existing antibody to rubella who were in 
contact with laboratory-Foonfirmed cases of rubella^ 
26# Rubella neutralising antibody in the control sera*
results of tests by members of the forking Party*
Table 1
in lïrfaats whose mothers had rubella 
the first sixteen weeks of pregnanoyt^«n*ia3« j 9JBi.fSftic«Wji»yrh%.,t, < g a « A  «Sti;uvkLi4fci2Lai5.**s.âJtidzJium-«itTLWl'*:A^4f¥K^li?t
Oardiovaooular Retioulo-endothelial
Patent ductus arteriosus Kepatosplenomegaly
Septal defects of the heart Cholestasis
Fallot's tetralogy Hopatic necrosis
Pulmonary stenosis and Giant cell hepatitis
coarctation Splenic fibrosis
Renal artery stenosis
%ooardial necrosis
Ophthalmic Nervous
nLMS.fc ^
Cataracts SSnoephalitis
M.orophthalmia Microcephaly
Pigmentary retinopathy Retardation
Glaucoma ''Cerebral pals;y”
Corneal clouding
Strabismus
Hystagmus
Coloboma
Chorioretinitis
Auditory MsoellanGous
.VTKi^Tjl.Y»
Maldevelopment of organ Interstitial %meumonitis
of Corti Osseous rarcefaction
Cochlear degeneration Oesophageal atresia
Stapes fixation Hypospadias
Growth retardation
Haemopoietic.l'A%km9LO#aK#kWlfK# Abnorml dermatoglyphios
Thrombocytopenic pm?pura
Anaemia « normocytic
hypoplastic
haemolytio
Beticulocytosis
Eormoblastaemia
Abnormal red coll
morphology
lymph&idenopathy
(%rpogammaglobulinaemia
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ÏPable 8
Rubella neutralising antibodj titres in 
15 batches of hmian inuaunoglobtilin *
Batch Reciprocal titres of
number neutralising antibody
IKG 106 240
107 160
fee 120
109 120
121 240
123 320
125 80
127 120
129 120
131 ,320
157 80
138 120
140 60
141 120
143 120
* Manufactured by the Lister Institute of Px.*eventive
Medicine
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1# OeiBOs of 3mbella (rate per 100 j 000) in ]jhg].and
and Wales dnring 1567 based on retnms to the
Royal College of General fraotitionera.
2» Cases of rubella (rate per 100,000) In England and
Wales during I568 baaed on returns to the Royal 
College of General Practitioners*
5# Percentage of 2,007 women of different ages who
lacked rubella neutralising antibody*
4* Immunity to rubella among 1,747 pregn&mt women
given 750 mg* immunoglobulin and the development 
of infection after contact with patients who had 
the clinical manifestât ions of rubella*
5» Immmity to rubella among 75 pregnant women given
750 mg* iiMiunoglobulln and the development of 
infection after homo contact with confirmed oases 
of rubella*
6* Interval between the dates of onset of rash in the
index case? Inoculation with immunoglobulin and 
development of maternal rash*
7* Xnmnmity to rubella among 545 uninoculated women
and the development of infection after home contact 
with patients who had the clinical manifestations 
of rubella*
8* Immunity to rubella among 208 iminoeiilated
women and the development of Infection after 
home contact with confirmed oases of xubellcu 
3* Cadets who suffered from clinical rubella at the
Metropolitan Police draining College before the 
start of the investigation*
10. Area of origin of 224 Metropolitan Police cadets
in contact with rubella^
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Figure 4
^Tmninitv to rubella among 1747 pregnant women glv#n 
750 mg. immunoglobulin and the develoraeiit of infection 
after oontaot with patiente who had the olinioal 
mnjitfea tat ions of rubella
CONTACTS WHO POSSESSED ANTIBODY TO RUBELLA 
SUSCEPTIBLE CONTACTS WHO DID NOT DEVELOP RUBELLA 
SUSCEPTIBLE CONTACTS WHO HAD A SUBCLINICAL INFECTION 
^ SUSCEPTIBLE CONTACTS WHO HAD A CLINICAL INFECTION
Mjwre 5
among 75 ixcegnant women given
mg. Upamnoglobiilin and the development of infection 
after home contact with oonfiimed cases of rubella
CONTACTS WHO POSSESSED ANTIBODY TO RUBELLA 
SUSCEPTIBLE CONTACTS WHO DID NOT DEVELOP RUBELLA 
SUSCEPTIBLE CONTACTS WHO HAD A SUBCLINICAL INFECTION 
SUSCEPTIBLE CONTACTS WHO HAD A CLINICAL INFECTION
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Figure 7
JjBcrunity to rubella among 543 uninooulated women 
and the development of infeotion after home oontaot 
with patients \âio had the olinioal manifestations of
rubella
CONTACTS WHO POSSESSED ANTIBODY TO RUBELLA 
SUSCEPTIBLE CONTACTS WHO DID NOT DEVELOP RUBELLA 
SUSCEPTIBLE CONTACTS WHO HAD A SUBCLINICAL INFECTION 
SUSCEPTIBLE CONTACTS WHO HAD A CLINICAL INFECTION
Figure 8 
to rubella among 208 uninoculafted^  
gpd, ;lhe development of infection after horn# oemtmat 
yith oonfirmed oases of rubella
CONTACTS WHO POSSESSED ANTIBODY TO RUBELLA
SUSCEPTIBLE CONTACTS WHO DID NOT DEVELOP RUBELLA 
SUSCEPTIBLE CONTACTS WHO HAD A SUBCLINICAL INFECTION 
SUSCEPTIBLE CONTACTS WHO HAD A CLINICAL INFECTION
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